# EDGAR Filing Document

**Accession Number:** 0001081188
**File Stem:** 0001081188-25-000006
**Filing Date:** 2025-7
**Character Count:** 249534
**Document Hash:** 9322960496129b8e26aa11aae421440e
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001081188-25-000006.hdr.sgml**: 20250701

**ACCESSION NUMBER**: 0001081188-25-000006

**CONFORMED SUBMISSION TYPE**: 1-A/A

**PUBLIC DOCUMENT COUNT**: 28

**FILED AS OF DATE**: 20250701

**DATE AS OF CHANGE**: 20250701

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** GOLD ENTERTAINMENT GROUP INC
- **CENTRAL INDEX KEY:** 0001081188
- **STANDARD INDUSTRIAL CLASSIFICATION:** ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 980206212
- **STATE OF INCORPORATION:** WY
- **FISCAL YEAR END:** 0131

**FILING VALUES:**
- **FORM TYPE:** 1-A/A
- **SEC ACT:** 1933 Act
- **SEC FILE NUMBER:** 024-12469
- **FILM NUMBER:** 251096084

**BUSINESS ADDRESS:**
- **STREET 1:** 2412 IRWIN ST
- **CITY:** MELBOURNE
- **STATE:** FL
- **ZIP:** 32901
- **BUSINESS PHONE:** 561-210-7553

**MAIL ADDRESS:**
- **STREET 1:** PO BOX 690041
- **CITY:** VERO BEACH
- **STATE:** FL
- **ZIP:** 32969

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** ADVANCED MEDICAL TECHNOLOGIES INC/CANADA
- **DATE OF NAME CHANGE:** 19990609

## Part

<br> **PART II – PRELIMINARY OFFERING CIRCULAR - FORM 1-A/A: TIER I Amendment 3**

<br> **An Offering statement pursuant to Regulation A relating to these securities has been filed with the Securities and Exchange Commission. Information contained in this Preliminary Offering Circular is subject to completion or amendment. These securities may not be sold nor may offers to buy be accepted before the Offering statement filed with the Securities and Exchange** **Commission is qualified. This Preliminary Offering Circular shall not constitute an offer to sell or the solicitation of an offer to buy nor may there be any sales of these securities in any state in which such offer, solicitation or sale would be unlawful before registration or qualification under the laws of any such state. We may elect to satisfy our obligation to deliver a Final Offering circular by sending you a notice within two business days after the completion of our sale to you that contains the URL where the Final Offering Circular or the Offering statement in which such Final Offering Circular was filed may be obtained.**

**PRELIMINARY OFFERING CIRCULAR**

**Dated: June 23, 2025**

**Subject to Completion<br>PURSUANT TO REGULATION A OF THE SECURITIES ACT OF 1933**

**GOLD ENTERTAINMENT GROUP, INC.**

**2412 Irwin St.**

**Melbourne, FL 32901**<br>

Best Efforts Offering of up to Seven Billion (7,000,000,000) Shares of Common Stock <br>Including Two Billion One hundred million (2,100,000,000) from selling shareholders and; <br>One hundred thousand PREFERRED SERIES B (100,000) convertible shares from a selling shareholder.

at an offering price of $0.00015 per Share

Minimum Investment: $15,000 (100,000,000 Shares)

Maximum Offering: $1,050,000

See The Offering - Page 9 and Securities Being Offered - Page 32. For Further Details and ITEM 14. SECURITIES BEING OFFERED with respect to the Selling Shareholders. Existing shareholders, including PREFERRED SERIES convertible shareholders, are free to sell their shares at the offering price as part of this registration. This Offering Will Commence Upon Qualification of this Offering by the Securities and Exchange Commission and Will Terminate 365 days from the date of qualification by the Securities And Exchange Commission, Unless Extended or Terminated Earlier By The Issuer

**PLEASE REVIEW ALL RISK FACTORS ON PAGES 10 THROUGH PAGE 20 BEFORE MAKING AN INVESTMENT IN THIS COMPANY. AN INVESTMENT IN THIS COMPANY SHOULD ONLY BE MADE IF YOU ARE CAPABLE OF EVALUATING THE RISKS AND MERITS OF THIS INVESTMENT AND IF YOU HAVE SUFFICIENT RESOURCES TO BEAR THE ENTIRE LOSS OF YOUR INVESTMENT, SHOULD THAT OCCUR.**

**THE UNITED STATES SECURITIES AND EXCHANGE COMMISSION DOES NOT PASS UPON THE MERITS OF OR GIVE ITS APPROVAL TO ANY SECURITIES OFFERED OR THE TERMS OF THE OFFERING, NOR DOES IT PASS UPON THE ACCURACY OR COMPLETENESS OF ANY OFFERING CIRCULAR OR OTHER SELLING LITERATURE. THESE SECURITIES ARE OFFERED PURSUANT TO AN EXEMPTION FROM REGISTRATION WITH THE COMMISSION; HOWEVER, THE COMMISSION HAS NOT MADE AN INDEPENDENT DETERMINATION THAT THE SECURITIES OFFERED HEREUNDER ARE EXEMPT FROM REGISTRATION.**

Because these securities are being offered on a "best efforts" basis, the following disclosures are hereby made:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Price to Public** | **Commissions (1)** | **Proceeds to <br> Company (2)** | **Proceeds to <br> Other Persons (3)** |
| Per Share | $0.00015 | $0 | $0.00015 |  |
| Minimum Investment | $15000 | $0 | $15000 |  |
| Maximum Offering | $1050000 | $0 | $735000 | $315000 |

---

(1) The Company shall pay no commissions to underwriters
for the sale of securities under this Offering.

(2) Does not reflect payment of expenses of this Offering, which are estimated to not exceed $50,000.00 and which include, among other
things, legal fees, accounting costs, reproduction expenses, due diligence, marketing, consulting, administrative services other
costs of blue sky compliance, and actual out-of-pocket expenses incurred by the Company selling the Shares. This amount represents
the proceeds of the offering to the Company, which will be used as set out in "USE OF PROCEEDS TO ISSUER."

(3) There are no finder's fees or other fees being paid to third parties from the proceeds of shares sold by the Company. The
Company shall receive no proceeds from the sale of 2,100,000,000 shares, nor the one hundred thousand PREFERRED SERIES B (100,000) convertible shares, being offered by the Selling Shareholders.

This Offering (the "Offering") consists of Common Stock (the "Shares" or individually, each a "Share") that is being offered on a "best efforts" basis, which means that there is no guarantee that any minimum amount will be sold. The Shares are being offered and sold by Gold Entertainment Group, Inc. a Wyoming Corporation (the "Company") and certain shareholders of the Company (the "Selling Shareholders"). There are 2,900,000,000 Shares being offered by the Company at a price of $0.00015 per Share with a minimum purchase of 100,,000,000 shares per investor. We may waive the minimum purchase requirement on a case-by-case basis in our sole discretion. There are an additional 2,100,000,000 shares of Common Stock being offered and a further one hundred thousand PREFERRED SERIES B (100,000) convertible shares by the Selling Shareholders. Under Rule 251(d)(2)(i)(C) of Regulation of Regulation A+, non-accredited, non-natural investors are subject to the investment limitation and may only invest funds which do not exceed 10% of the greater of the purchaser's revenue or net assets (as of the purchaser's most recent fiscal year end). A non-accredited, natural person may only invest funds which do not exceed 10% of the greater of the purchaser's annual income or net worth (please see below on how to calculate your net worth). The maximum aggregate amount of the Shares offered 5,000,000,000 Shares of Common Stock, and a further one hundred thousand PREFERRED SERIES B (100,000) convertible shares, is seven hundred and fifty-thousand dollars ($750,000). There is no minimum number of Shares that needs to be sold in order for funds to be released to the Company and for this Offering to close. The Company will retain all proceeds received from the shares sold on their account in this offering. The Company will not receive any proceeds from sales by the Selling Shareholders.

The Minimum Investment, per investor, may be waived at the Management's discretion. <br>

Our Common Stock is currently quoted on the OTC Pink tier of the OTC Market Group, Inc. under the symbol "GEGP" On September 15, 2024, the last reported sale price of our common stock was $0.0002 (made on September 9, 2024).

The Shares are being offered pursuant to Regulation A of Section 3(b) of the Securities Act of 1933, as amended, for Tier I offerings. The Shares will only be issued to purchasers who satisfy the requirements set forth in Regulation A. The offering is expected to expire on the first of: (i) all of the Shares offered are sold; or (ii) the close of business 365 days from the date of qualification by the Commission, unless sooner terminated or extended by the Company's CEO. Pending each closing, payments for the Shares will be paid directly to the Company. Funds will be immediately transferred to the Company where they will be available for use in the operations of the Company's business in a manner consistent with the "USE OF PROCEEDS TO ISSUER" in this Offering Circular.

**VOTING RIGHTS OF COMMON & PREFERRED SHARES**

There are two classes of PREFERRED SHARES, A and B, and one class of COMMON SHARES. Each of these classes effects the voting control of the Company now and in the foreseeable future.

* PREFERRED SERIES A - Vote as Common Shares at the ratio of one PREFERRED SERIES A share equals 5,000 Common Shares.
These shares are designated as non-convertible, therefore they act solely as a voting control class of shares only. Each SERIES A Preferred Share votes at 1:5,000 to Common Stock. Therefore this represents majority voting control of the Company.

* PREFERRED SERIES B - PREFERRED SERIES B Shares are convertible to Common Shares, at the shareholders discretion, at 50% of 5-day trading average prior to conversion. When converted, these common shares have the same voting rights as others in the same class of securities. The PREFERRED SERIES B Shares do not have specific voting rights prior to conversion into Common Shares.

* COMMON SHARES - Common Shares vote one vote per share. The three directors and their associated corporate entities, control Collectively they own 9,928,500,000 Common Shares out of the 16,812,001,513 Issued and Outstanding. This represents 59% of the Common Shares. SEE ALSO CONTROLLING SHAREHOLDERS below.

CONTROLLING SHAREHOLDERS - Voting control of the company is held by three parties as a whole. Each of these parties are also the three board members and both board seats. Collectively they own 9,928,500,000 Common Shares out of the 16,812,001,513 Issued and Outstanding before the sale, and a further 10,000,000,000 (ten billion) votes due to the ownership of all of the PREFERRED SERIES A shares. This represents a majority voting control both free and post offering, assuming the sale of all 4,900,000,000 new shares included in this registration. The rights and amounts are described in detail in ITEM 12. SECURITY OWNERSHIP OF MANAGEMENT AND CERTAIN SECURITY HOLDERS on Page 20.

**THIS OFFERING CIRCULAR DOES NOT CONSTITUTE AN OFFER OR SOLICITATION IN ANY JURISDICTION IN WHICH SUCH AN OFFER OR SOLICITATION WOULD BE UNLAWFUL. NO PERSON HAS BEEN AUTHORIZED TO GIVE ANY INFORMATION OR TO MAKE ANY REPRESENTATIONS CONCERNING THE COMPANY OTHER THAN THOSE CONTAINED IN THIS OFFERING CIRCULAR, AND IF GIVEN OR MADE, SUCH OTHER INFORMATION OR REPRESENTATION MUST NOT BE RELIED UPON.**

**PROSPECTIVE INVESTORS ARE NOT TO CONSTRUE THE CONTENTS OF THIS OFFERING CIRCULAR, OR OF ANY PRIOR OR SUBSEQUENT COMMUNICATIONS FROM THE COMPANY OR ANY OF ITS EMPLOYEES, AGENTS OR AFFILIATES, AS INVESTMENT, LEGAL, FINANCIAL OR TAX ADVICE.**

GENERALLY, NO SALE MAY BE MADE TO YOU IN THIS OFFERING IF THE AGGREGATE PURCHASE PRICE YOU PAY IS MORE THAN 10% OF THE GREATER OF YOUR ANNUAL INCOME OR NET WORTH. DIFFERENT RULES APPLY TO ACCREDITED INVESTORS AND NON-NATURAL PERSONS. BEFORE MAKING ANY REPRESENTATION THAT YOUR INVESTMENT DOES NOT EXCEED APPLICABLE THRESHOLDS, WE ENCOURAGE YOU TO REVIEW RULE 251(d)(2)(i)(C) OF REGULATION A. FOR GENERAL INFORMATION ON INVESTING, WE ENCOURAGE YOU TO REFER TO WWW.INVESTOR.GOV (WHICH IS NOT INCORPORATED BY REFERENCE INTO THIS OFFERING CIRCULAR).

This Offering is inherently risky. See "Risk Factors" beginning on page 10.

Sales of these securities will commence within two calendar days of the qualification date and the filing of a Form 253(g)(2) Offering Circular AND it will be a continuous Offering pursuant to Rule 251(d)(3)(i)(F).

The Company is following the "Offering Circular" format of disclosure under Regulation A.

**AN OFFERING STATEMENT PURSUANT TO REGULATION A RELATING TO THESE SECURITIES HAS BEEN FILED WITH THE SECURITIES AND EXCHANGE COMMISSION. INFORMATION CONTAINED IN THIS PRELIMINARY OFFERING CIRCULAR IS SUBJECT TO COMPLETION OR AMENDMENT. THESE SECURITIES MAY NOT BE SOLD NOR MAY OFFERS TO BUY BE ACCEPTED BEFORE THE OFFERING STATEMENT FILED WITH THE COMMISSION IS QUALIFIED. THIS PRELIMINARY OFFERING CIRCULAR SHALL NOT CONSTITUTE AN OFFER TO SELL OR THE SOLICITATION OF AN OFFER TO BUY NOR MAY THERE BE ANY SALES OF THESE SECURITIES IN ANY STATE IN WHICH SUCH OFFER, SOLICITATION OR SALE WOULD BE UNLAWFUL BEFORE REGISTRATION OR QUALIFICATION UNDER THE LAWS OF SUCH STATE. THE COMPANY MAY ELECT TO SATISFY ITS OBLIGATION TO DELIVER A FINAL OFFERING CIRCULAR BY SENDING YOU A NOTICE WITHIN TWO BUSINESS DAYS AFTER THE COMPLETION OF THE COMPANY'S SALE TO YOU THAT CONTAINS THE URL WHERE THE FINAL OFFERING CIRCULAR OR THE OFFERING STATEMENT IN WHICH SUCH FINAL OFFERING CIRCULAR WAS FILED MAY BE OBTAINED.** 

**<u>NASAA UNIFORM LEGEND</u>**

**FOR RESIDENTS OF ALL STATES: THE PRESENCE OF A LEGEND FOR ANY GIVEN STATE REFLECTS ONLY THAT A LEGEND MAY BE REQUIRED BY THAT STATE AND SHOULD NOT BE CONSTRUED TO MEAN AN OFFER OR SALE MAY BE MADE IN A PARTICULAR STATE. IF YOU ARE UNCERTAIN AS TO WHETHER OR NOT OFFERS OR SALES MAY BE LAWFULLY MADE IN ANY GIVEN STATE, YOU ARE HEREBY ADVISED TO CONTACT THE COMPANY. THE SECURITIES DESCRIBED IN THIS OFFERING CIRCULAR HAVE NOT BEEN REGISTERED UNDER ANY STATE SECURITIES LAWS (COMMONLY CALLED 'BLUE SKY' LAWS).**

**IN MAKING AN INVESTMENT DECISION INVESTORS MUST RELY ON THEIR OWN EXAMINATION OF THE PERSON OR ENTITY CREATING THE SECURITIES AND THE TERMS OF THE OFFERING, INCLUDING THE MERITS AND RISKS INVOLVED. THESE SECURITIES HAVE NOT BEEN RECOMMENDED BY ANY FEDERAL OR STATE SECURITIES COMMISSION OR REGULATORY AUTHORITY. FURTHERMORE, THE FOREGOING AUTHORITIES HAVE NOT CONFIRMED THE ACCURACY OR DETERMINED THE ADEQUACY OF THIS DOCUMENT. ANY REPRESENTATION TO THE CONTRARY IS A CRIMINAL OFFENSE.**

**<u>NOTICE TO FOREIGN INVESTORS</u>**

**IF THE PURCHASER LIVES OUTSIDE THE UNITED STATES, IT IS THE PURCHASER'S RESPONSIBILITY TO FULLY OBSERVE THE LAWS OF ANY RELEVANT TERRITORY OR JURISDICTION OUTSIDE THE UNITED STATES IN CONNECTION WITH ANY PURCHASE OF THE SECURITIES, INCLUDING OBTAINING REQUIRED GOVERNMENTAL OR OTHER CONSENTS OR OBSERVING ANY OTHER REQUIRED LEGAL OR OTHER FORMALITIES. THE COMPANY RESERVES THE RIGHT TO DENY THE PURCHASE OF THE SECURITIES BY ANY FOREIGN PURCHASER.**

**<u>PATRIOT ACT RIDER</u>**

The Investor hereby represents and warrants that Investor is not, nor is it acting as an agent, representative, intermediary or nominee for, a person identified on the list of blocked persons maintained by the Office of Foreign Assets Control, U.S. Department of Treasury. In addition, the Investor has complied with all applicable U.S. laws, regulations, directives, and executive orders relating to anti-money laundering , including but not limited to the following laws: (1) the Uniting and Strengthening America by Providing Appropriate Tools Required to Intercept and Obstruct Terrorism Act of 2001, Public Law 107-56, and (2) Executive Order 13224 (Blocking Property and Prohibiting Transactions with Persons Who Commit, Threaten to Commit, or Support Terrorism) of September 23, 2001.

**NO DISQUALIFICATION EVENT ("BAD BOY" DECLARATION)**

**NONE OF THE COMPANY, ANY OF ITS PREDECESSORS, ANY AFFILIATED ISSUER, ANY DIRECTOR, EXECUTIVE OFFICER, OTHER OFFICER OF THE COMPANY PARTICIPATING IN THE OFFERING CONTEMPLATED HEREBY, ANY BENEFICIAL OWNER OF 20% OR MORE OF THE COMPANY'S OUTSTANDING VOTING EQUITY SECURITIES, CALCULATED ON THE BASIS OF VOTING POWER, NOR ANY PROMOTER (AS THAT TERM IS DEFINED IN RULE 405 UNDER THE SECURITIES ACT OF 1933) CONNECTED WITH THE COMPANY IN ANY CAPACITY AT THE TIME OF SALE (EACH, AN "***ISSUER COVERED PERSON***") IS SUBJECT TO ANY OF THE "BAD ACTOR" DISQUALIFICATIONS DESCRIBED IN RULE 506(D)(1)(I) TO (VIII) UNDER THE SECURITIES ACT OF 1933 (A "***DISQUALIFICATION EVENT***"), EXCEPT FOR A DISQUALIFICATION EVENT COVERED BY RULE 506(D)(2) OR (D)(3) UNDER THE SECURITIES ACT. THE COMPANY HAS EXERCISED REASONABLE CARE TO DETERMINE WHETHER ANY ISSUER COVERED PERSON IS SUBJECT TO A DISQUALIFICATION EVENT.**

**Continuous Offering**

Under Rule 251(d)(3) to Regulation A, the following types of continuous or delayed Offerings are permitted, among others: (1) securities offered or sold by or on behalf of a person other than the issuer or its subsidiary or a person of which the issuer is a subsidiary; (2) securities issued upon conversion of other outstanding securities; or (3) securities that are part of an Offering which commences within two calendar days after the qualification date. These may be offered on a continuous basis and may continue to be offered for a period in excess of 30 days from the date of initial qualification. They may be offered in an amount that, at the time the Offering statement is qualified, is reasonably expected to be offered and sold within one year from the initial qualification date. No securities will be offered or sold "at the market." The supplement will not, in the aggregate, represent any change from the maximum aggregate Offering price calculable using the information in the qualified Offering statement. This information will be filed no later than two business days following the earlier of the date of determination of such pricing information or the date of first use of the Offering circular after qualification.

Sale of these shares will commence within two calendar days of the qualification date and it will be a continuous Offering pursuant to Rule 251(d)(3)(i)(F).

Subscriptions are irrevocable and the purchase price is non-refundable as expressly stated in this Offering Circular. The Company, by determination of the Board of Directors, in its sole discretion, may issue the Securities under this Offering for cash, promissory notes, services, and/or other consideration without notice to subscribers. All proceeds received by the Company from subscribers for this Offering will be available for use by the Company upon acceptance of subscriptions for the Securities by the Company.

**<u>Forward Looking Statement Disclosure</u>**

**This Form 1-A, Offering Circular, and any documents incorporated by reference herein or therein contain forward-looking statements and are subject to risks and uncertainties. All statements other than statements of historical fact or relating to present facts or current conditions included in this Form 1-A, Offering Circular, and any documents incorporated by reference are forward-looking statements. Forward-looking statements give the Company's current reasonable expectations and projections relating to its financial condition, results of operations, plans, objectives, future performance, and business. You can identify forward-looking statements by the fact that they do not relate strictly to historical or current facts. These statements may include words such as 'anticipate,' 'estimate,' 'expect,' 'project,' 'plan,' 'intend,' 'believe,' 'may,' 'should,' 'can have,' 'likely' and other words and terms of similar meaning in connection with any discussion of the timing or nature of future operating or financial performance or other events. The forward-looking statements contained in this Form 1-A, Offering Circular, and any documents incorporated by reference herein or therein are based on reasonable assumptions the Company has made in light of its industry experience, perceptions of historical trends, current conditions, expected future developments and other factors it believes are appropriate under the circumstances. As you read and consider this Form 1-A, Offering Circular, and any documents incorporated by reference, you should understand that these statements are not guarantees of performance or results. They involve risks, uncertainties (many of which are beyond the Company's control) and assumptions. Although the Company believes that these forward-looking statements are based on reasonable assumptions, you should be aware that many factors could affect its actual operating and financial performance and cause its performance to differ materially from the performance anticipated in the forward-looking statements. Should one or more of these risks or uncertainties materialize, or should any of these assumptions prove incorrect or change, the Company's actual operating and financial performance may vary in material respects from the performance projected in these forward- looking statements. Any forward-looking statement made by the Company in this Form 1-A, Offering Circular or any documents incorporated by reference herein speaks only as of the date of this Form 1-A, Offering Circular or any documents incorporated by reference herein. Factors or events that could cause our actual operating and financial performance to differ may emerge from time to time, and it is not possible for the Company to predict all of them. The Company undertakes no obligation to update any forward-looking statement, whether as a result of new information, future developments or otherwise, except as may be required by law.**

**<u>About This Form 1-A and Offering Circular</u>**

**In making an investment decision, you should rely only on the information contained in this Form 1-A and Offering Circular. The Company has not authorized anyone to provide you with information different from that contained in this Form 1-A and Offering Circular. We are offering to sell, and seeking offers to buy the Shares only in jurisdictions where offers and sales are permitted. You should assume that the information contained in this Form 1-A and Offering Circular is accurate only as of the date of this Form 1-A and Offering Circular, regardless of the time of delivery of this Form 1-A and Offering Circular. Our business, financial condition, results of operations, and prospects may have changed since that date. Statements contained herein as to the content of any agreements or other documents are summaries and, therefore, are necessarily selective and incomplete and are qualified in their entirety by the actual agreements or other documents.** 

 **TABLE OF CONTENTS**

---

| | |
|:---|:---|
| ITEM 1 Cover Page of Offering Circular | - |
| ITEM 2 Summary Information | 6 |
| <br> ITEM 3 Risk Factors - COVID-19 Risks Related to the Company | <br> 9 |
| <br> ITEM 3 Risk Factors (contd)  | <br> 9 |
| <br> ITEM 4 Dilution | <br> 15 |
| <br> ITEM 5. Plan of Distribution and Selling Securityholders | <br> 16 |
| <br> ITEM 6 Use of Proceeds | <br> 17 |
| <br> ITEM 7 Description of Business | <br> 18 |
| <br> ITEM 8. Description of Property | <br> 22 |
| <br> ITEM 9. Managements Discussion and Analysis | <br> 23 |
| <br> ITEM 10. Directors, Executives, and Significant Employees | <br> 27 |
| <br> ITEM 11. COMPENSATION OF DIRECTORS AND EXECUTIVE OFFICERS | <br> 29 |
| <br> ITEM 12. Security Ownership of Management and Control Persons | <br> 30 |
| <br> ITEM 13. Interest of Management and Others In Certain Transactions | <br> 31 |
| <br> ITEM 14. Securities Being Offered | <br> 32 |
| <br> ITEMS 15 Financial Statements | <br> F1 |
| <br> ITEMS 15 Notes to Financial Statements | <br> F6 - F7 |
| <br> Exhibits | <br> F8 |
| <br> Signatures |  |

---

------

**SUMMARY OF INFORMATION IN OFFERING CIRCULAR**

As used in this prospectus, references to the Company, company, we, our, us, The Company, or Company Name refer to GOLD ENTERTAINMENT GROUP, INC., unless the context otherwise indicated.

You should carefully read all information in the prospectus, including the financial statements and their explanatory notes, under the Financial Statements prior to making an investment decision.

---

| | |
|:---|:---|
| <u>**The Company**</u> |  |
| Organization: | Gold Entertainment Group, Inc. was originally incorporated in the State of Nevada on February 3, 1999 as a C corporation under the name ADVANCED MEDICAL TECHNOLOGIES INC. / CANADA. The fiscal year end is January 31st. <br>On June 27, 2018, Gold Entertainment Group, Inc. ("we" or "Company") entered into an agreement with IceLounge Media Inc., a Wyoming corporation ("ICELOUNGE"), (the "Agreement"). Pursuant to the terms of the Agreement, the Company authorized a new class of Preferred Shares. The new class, SERIES B Preferred Shares were issued as part of the payment due to the Company' CEO and Director, Mr. Fytton, for the acquisition of the Company' controlling block of Series A Preferred Stock, by ICELOUNGE; whose rights remain unchanged. Following conformation from the State of Florida of these changes, the Effective Date for the previously announced ICELOUNGE Agreement is amended to be August 10, 2018. <br> On the effective date of August 10, 2018, Mr. Fytton resigned as President and CEO, and was appointed as Chief Financial Officer and Director of the Company. Our principal office is located at 2412 Irwin St. Melbourne, FL 32901 <br> In November 2023, M. Schiegal resigned as CEO and Director and retained his shares. Mr Fytton was, again, appointed as CEO and Cathy Julian as CFO and as a Director. |
| Capitalization: | Our articles of incorporation provide for the issuance of up to (i) 25,000,000,000 shares of Common Stock, par value $0.0001 and (ii) 5,000,000 shares of Preferred Stock, par value $0.0001. As of the date of this Prospectus there are 16,812,001,513 shares of Common Stock, and 2,000,000 shares of Preferred SERIES A and 272,000 Preferred SERIES B issued and outstanding. |
| Management: | Our Chief Executive Officer and Director is Hamon Fytton. He also acts as President and Secretary. Cathy Julian as CFO and Director, the only other officer, and one other director of the Company as of the date of this filing. The Company does not plan to add additional Officers and Directors upon qualification of this offering. The CEO spends approx. 25 hours per month to the affairs of the Company. This is expected to continue following qualification of this offering and as Company operations commence. |
| Controlling Shareholders: | Our CEO owns 3,309,500,000 shares of Common Stock. The shareholders of IceLounge Media, Inc., collectively own 3,309,500,000 shares of Common Stock and are the 100% owner of the SERIES A Preferred shares. The CFO also owns 3,309,500,000 shares of Common Stock. As such, our current CEO is dependent on the other Officers and Directors to be able to exert significant influence over the affairs of the Company. |

---

---

| | |
|:---|:---|
| Independence: | We are not a blank check company, as such term is defined by Rule 419 promulgated under the Securities Act of 1933, as amended, as we have a specific business plan and we presently have no binding plans or intentions to engage in a merger or acquisition with an unidentified company, companies, entity or person. As of the date of this offering circular, the Company does not have any binding agreements, letters of intent, memorandums of understanding, or other legally enforceable commitments to engage in a merger or acquisition with any specific identified company. While the Company's business strategy includes pursuing strategic acquisitions in the healthcare and medical device industry when suitable opportunities arise, any such transactions will be subject to the Company's due diligence process, board of directors approval, negotiation of definitive agreements, and the availability of adequate financing. The Company has not entered into any preliminary agreements, signed term sheets, or binding obligations with respect to any particular acquisition target as of this filing date  |

---

------

---

| | |
|:---|:---|
| <u>**Our Business**</u> |  |
| Description of Operations: | Our corporate office is located at 2412 Irwin St., Melbourne, FL 32901. This is the office of our CEO, and is provided at no cost to the Company. The Company also has an office in Hudson, Florida for the Medical Device operations. This is provided at no cost to the Company by its CFO who, in another company, owns the building.<br>|
| Historical Operations: | Commencing January 31, 2004, Gold Entertainment Group, Inc. was a developer and marketer of a national multi-level, fixed- price DVD rental program, and sought to become a leading home entertainment sales and rental company. Gold Entertainment Group, Inc. marketed its products and programs exclusively through an independent network of distributors whereby its distributors promoted the Company' DVD rental service with products shipped directly to consumers. The Company maintains the web site: www.GoldEntertainment.com<br> At the time, the Company had operations through its main office in Florida, and a Canadian subsidiary in Toronto, Ontario. As of our quarterly report ending October 31, 2024 we have an accumulated deficit of $(20321). <br>|
| Growth Strategy: | <br> The Company has expanded its healthcare operations with a 20% ownership in MEDWORX A INC, a medical billing company, during the first quarter of 2024.. Upon completion of this offering, and following a successful capital raise, the Company intends to seek other acquisitions in the healthcare industry. The timing of commencement of expanding operations may be influenced by our relative success of this offering. We may not raise sufficient proceeds through this offering in order to fully execute our business plans.<br>|
| Expansion Strategy: | Its current business plan is the expansion of this business following the successful funding through this offering. This will involve the expansion of its existing products into new markets and the development and acquisition additional products. This will be accomplished through business acquisitions, joint ventures or re-sale agreement, or any combination thereof.<br>The Company also, intends to use its capital stock, debt, or a combination of these to effect an acquisition of a complimentary business. We are an emerging growth company, and we expect to use substantially all of the net proceeds from this offering to engage in acquisition and product development business described herein. We expect to build a high-quality brand portfolio intended to generate income and to provide capital preservation, capital appreciation and portfolio diversification.<br>|
| Current Operations: | The Company is a distributor of orthopedic products. |
| Growth Strategy: | The Company will expand its healthcare operations upon completion of this offering, and following a successful capital raise. The timing of commencement of expanding operations may be influenced by our relative success of this offering. We may not raise sufficient proceeds through this offering in order to fully execute our business plans.<br>|
| <u>**The Offering**</u> |  |
| Securities Offered: | 5,000,000,000 shares of Common Stock at $0.00015 per share.<br>|
| Common Stock Outstanding before the Offering: | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 16,812,001,513 shares of Common Stock.  |
| Common Stock Outstanding after the Offering | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 19,712,001,513 shares of Common Stock.  |
| Use of Proceeds | The proceeds will be deployed for acquisitions and product development and related working capital expenses. See ITEM 6 for a detailed explation. |
| Termination of the Offering: | The offering will commence as soon as practicable after this Offering Circular has been qualified by the Securities and Exchange Commission (the "SEC") and the relevant state regulators, as necessary and will terminate on the sooner of the sale of the maximum number of shares being sold, twelve months from the effective date of this Offering Statement or the decision by Company management to deem the offering closed.  |
| Offering Cost: | We estimate our total offering registration costs to be $50,000. If we experience a shortage of funds prior to funding, our CFO and director has verbally agreed to advance funds to the Company to allow us to pay for offering costs, filing fees, and correspondence with our shareholders; however our officer and director has no legal obligation to advance or loan funds to the Company. |
| Market for the Shares: | The Shares being offered herein are not listed for trading on any exchange or automated quotation system. The Company does not intend to seek such a listing at any time hereinafter.  |

---

------

**ITEM 3. RISK FACTORS**

<u>**COVID-19 Risks Related to the Company**</u>

<u>**The COVID-19 pandemic poses specific risks related to our Company**</u>

The COVID-19 pandemic poses specific risks related to our Company. Specifically it makes it difficult for us to evaluate specific business opportunities, visit certain areas easily, meet with potential investors and joint venture partners. Some investment companies may also determine that because we are a company with limited revenue and assets, that we will delayed unreasonably in our ability to create new products and expand in a timely manner. This may influence them in a negative manner and make decisions based on those estimates of our potential future performance.

We intend to pursue business expansion via acquisition. With these existing opportunities, there may be unforeseen delays and late payments due to COVID-19. This may reduce our ability to obtain investment financing for those opportunities. This will require the Company to acquire these opportunities being asked to agree to unreasonable terms or abandon those opportunities altogether. This will increase our cost and create delays in acquiring opportunities.

There is, however, a potential upside to the COVID-19 disruption. If we can obtain the confidence of investors, we may be able to target opportunities where the income has been delayed or disrupted by the pandemic. We would typically have to make a fast offer on such opportunities in order to negotiate a sale. We would expect to obtain such opportunities at a discount relative to a normal market appraisal.

In either case the COVID-19 pandemic will cause continued disruption in the consumer market for an unknown time period. This may result in the delays in the Company' operations.

Investing in our shares involves risk. In evaluating the Company and an investment in the shares, careful consideration should be given to the following risk factors, in addition to the other information included in this Offering circular. Each of these risk factors could materially adversely affect The Company' business, operating results or financial condition, as well as adversely affect the value of an investment in our shares. The following is a summary of the most significant factors that make this offering speculative or substantially risky. The company is still subject to all the same risks that all companies in its industry, and all companies in the economy, are exposed to. These include risks relating to economic downturns, political and economic events and technological developments (such as cyber-security). Additionally, early-stage companies are inherently more risky than more developed companies. You should consider general risks as well as specific risks when deciding whether to invest.

<u>**Risks Related to the Company**</u>

**<u>*The Company has a limited operating history in its current business operations.*</u>**

Our company was incorporated on February 3, 1999, and were in a different line of business, which makes a present day evaluation of our business operations difficult. In addition, we have recently shifted our focus from the technology and internet operations to becoming a distributor of orthopedic products. There is a risk that we will be unable to successfully continue to operate this new line of business or be able to successfully integrate it with our current management and structure. Our estimates of capital and personnel required for our new line of business are based on the experience of management and businesses that are familiar to them. We are subject to the risks such as our ability to implement our business plan, market acceptance of our proposed business and services, under-capitalization, cash shortages, limitations with respect to personnel, financing and other resources, competition from better funded and experienced companies, and uncertainty of our ability to generate revenues. There is no assurance that our activities will be successful or will result in any revenues or profit, and the likelihood of our success must be considered in light of the stage of our development. In addition, no assurance can be given that we will be able to consummate our business strategy and plans, as described herein, or that financial, technological, market, or other limitations may force us to modify, alter, significantly delay, or significantly impede the implementation of such plans. We have insufficient results for investors to use to identify historical trends or even to make quarter to quarter comparisons of our operating results. You should consider our prospects in light of the risk, expenses and difficulties we will encounter as an early-stage company. Our revenue and income potential is unproven, and our business model is continually evolving. We are subject to the risks inherent to the operation of a new business enterprise and cannot assure you that we will be able to successfully address these risks.

<u>***The company has realized significant operating losses to date and expects to incur losses in the future***</u>

The company has operated at a loss since inception, and these losses are likely to continue. The Company' net loss for the period ending October 31, 2024 is $20,227. Until the company achieves profitability, it will have to seek other sources of capital in order to continue operations.

<u>**The Company has limited capitalization and a lack of working capital and as a result is dependent on raising funds to grow and expand its business.**</u>

The Company lacks sufficient working capital in order to execute its business plan. The ability of the Company to move forward with its objective is therefore highly dependent upon the success of the offering described herein. Should we fail to obtain sufficient working capital through this offering we may be forced to abandon our business plan.

<u>**Because we do not have a recent history of operations we may not be able to successfully implement our business plan.**</u>

We are a public company trading under the symbol GEGP. We have limited recent operational history, accordingly, our future operations are subject to similar risks inherent in the establishment of a new business enterprise, including access to capital, successful implementation of our business plan and generating revenue from operations. We cannot assure you that our intended activities or plan of operation will be successful or result in revenue or profit to us and any failure to implement our business plan may have a material adverse effect on the business of the Company.

------

 <u>**We are a publicly traded corporation with over ten years of operating history, however we may not be able to successfully operate our business or generate sufficient operating cash flows to make or sustain distributions to our stockholders.**</u>

Our growth strategy could fail or present unanticipated problems for our business in the future, which could adversely affect our ability to make acquisitions or realize anticipated benefits of those acquisitions. Our financial condition, results of operations and ability to make or sustain distributions to our stockholders will depend on many factors, including:

---

| |
|:---|
| diversion of management' attention; |
| our ability to consummate financing on favorable terms; |
| the need to integrate acquired operations; |
| potential loss of key employees of the acquired companies; |
| an increase in our expenses and working capital requirements; and |
| economic conditions in our markets, as well as the condition of the financial investment markets and the economy generally. |

---

<u> </u><u>**We are dependent on funding from our Officers and Directors and the sale of our securities to fund our operations**</u>**.**

We are dependent on funding from our Officers and Directors and the sale of our securities to fund our operations, and will remain so until we generate sufficient revenues to pay for our operating costs. Our Officers and Directors have not made any written commitments with respect to providing a source of liquidity in the form of cash advances, loans and/or financial guarantees. There can be no guarantee that we will be able to successfully sell our equity securities. Such liquidity and solvency problems may force the Company to cease operations if additional financing is not available. No known alternative resources of funds are available in the event we do not generate sufficient funds from operations.

<u>**The Company is dependent on key personnel and loss of the services of any of these individuals could adversely affect the conduct of the Company' business.**</u>

Our business plan is significantly dependent upon the ability to hire and retain qualified individuals and key personal, who may be appointed as officers and directors, and their continued participation in our Company. It may be difficult to replace any of them at an early stage of development of the Company. The loss by or unavailability to the Company of their services would have an adverse effect on our business, operations and prospects, in that our inability to replace them could result in the loss of your investment. There can be no assurance that we would be able to locate or employ personnel to replace any of our officers, should their services be discontinued. In the event that we are unable to locate or employ personnel to replace our officers we would be required to cease pursuing our business opportunity, which would result in a loss of your investment.

------

<u>**The Company may not be able to attain profitability without additional funding, which may be unavailable.**</u>

The Company has limited capital resources. Unless the Company begins to generate sufficient revenues to finance operations as a going concern, the Company may experience liquidity and solvency problems. Such liquidity and solvency problems may force the Company to cease operations if additional financing is not available. No known alternative resources of funds are available in the event we do not generate sufficient funds from operations.

<u>**Risks Relating to Our Business**</u>

<u>**The profitability of attempted acquisitions and other business developments is uncertain.**</u>

We intend to acquire and develop new marketing technologies and companies selectively. The acquisition and development of these technologies entails risks that investments may fail to perform in accordance with expectations. In undertaking these projects, we will incur certain risks, including the expenditure of funds on, and the devotion of management' time to, transactions that may not come to fruition. Additional risks inherent in the projects include risks that the intended advertisers will not accept our new products and may not achieve additional anticipated sales using these new products. As a result capital expenditure used to develop these new products, may be amortized over a much longer time than expected. Expenses may be greater than anticipated.

<u>**Some of our investments may be illiquid.**</u>

Because some of our investments may be illiquid, our ability to vary our portfolio promptly in response to economic or other conditions will be limited. This is because there may be apprehension among investors in general, because of relative newness pf the companies we attract as investments or acquisition. The foregoing and any other factor or event that would impede our ability to respond to adverse changes in the performance of our investments could have an adverse effect on our financial condition and results of operations.

------

 <u>**Risks Relating to Our Business - *continued***</u>

<u>**Our opportunities may not be diversified.**</u>

Our potential profitability and our ability to diversify our investments may be limited, both geographically and by type of opportunities purchased. We will be able to purchase or develop additional opportunities only as additional funds are raised and only if owners of businesses accept our stock in exchange for an interest in the target business. Our opportunities may not be well diversified and their economic performance could be affected by changes in local economic conditions.

<u>**Competition with third parties for opportunities and other investments may result in our paying higher prices for opportunities which could reduce our profitability and the return on your investment.**</u>

We compete with many other entities engaged in brand development and investment activities, including individuals, corporations, REITs, and limited partnerships, many of which have greater resources than we do. Some of these investors may enjoy significant competitive advantages that result from, among other things, a lower cost of capital and enhanced operating efficiencies. In addition, the number of entities and the amount of funds competing for suitable investments may increase. Any such increase would result in increased demand for these assets and increased prices. If competitive pressures cause us to pay higher prices for opportunities, our ultimate profitability may be reduced and the value of our opportunities may not appreciate or may decrease significantly below the amount paid for such opportunities. At the time we elect to dispose of one or more of our opportunities, we will be in competition with sellers of similar opportunities to locate suitable purchasers, which may result in us receiving lower proceeds from the disposal or result in us not being able to dispose of the property due to the lack of an acceptable return. This may cause you to experience a lower return on your investment.

<u>**The Company may not be able to effectively control the timing and costs relating to the acquisition opportunities, which may adversely affect the Companys operating results and the its ability to make a return on its investment or disbursements of dividends or interest to our shareholders.**</u>

Nearly all of the opportunities to be acquired by the Company will require some level of capital expenditure immediately upon their acquisition or in the near future. The Company may acquire opportunities that it plans to extensively develop and require significant capital infusion. The Company also may acquire opportunities that it expects to be in good standing and operations, but has problems that require extensive capital expenditure to fix.

If the Companys assumptions regarding the costs or timing of business improvements prove to be materially inaccurate, the Companys operating results and ability to make distributions to our Shareholders may be adversely affected.

 <u>**The Company has not yet identified any specific opportunities to acquire or improve with net proceeds of this offering, and you will be unable to evaluate the economic merits of the company' investments made with such net proceeds before making an investment decision to purchase the Companys securities.**</u>

The Company will have broad authority to invest a portion of the net proceeds of this offering in any opportunities the Company may identify in the future, and the Company may use those proceeds to make investments and improvements with which you may not agree. You will be unable to evaluate the economic merits of the Company' opportunities before the Company invests in them and the Company will be relying on its ability to select attractive investment opportunities. In addition, the Company' investment policies may be amended from time to time at the discretion of the Company' Management, without out notice to the Company' Shareholders. These factors will increase the uncertainty and the risk of investing in the Company' securities.

 <u>**Effective January 31, 2025, the Company has divested itself of its 20% equity in MEDWORX.**</u>

The Company has divested itself of its 20% equity in MEDWORX effective January 31, 2025. The Company and its Management, no longer feels that this is beneficial to retain partial ownership unless it intends to acquire majority control in the near future, which it does not. Therefore the Company has received, by mutual agreement and consent, fifty- thousand (50,000) PREFERRED SERIES B shares in exchange for the return of the MEDWORX equity. Following this transaction, the issued and outstanding PREFERRED SERIES B shares are reduced from 322,000 to 272,000.

------

<u>**Risks Related to Our Securities**</u>

<u>**There is a limited established trading market for our Common Stock and if a trading market does not develop, purchasers of our securities may have difficulty selling their securities**</u>

GEGP is a non-reporting company as defined by the SEC. It does not presently, as of the date of this prospectus, file periodic reports with the SEC. It is quoted on the OTC Markets as a PINK sheet company. There is a limited established public trading market for our Common Stock and an active trading market in our securities may not develop or, if developed, may not be sustained. While we intend to seek a quotation on a major national exchange or automated quotation system in the future, there can be no assurance that any such trading market will develop, and purchasers of the common stock may have difficulty selling their common stock. No market makers have committed to becoming market makers for our common stock and none may do so.

<u>**The offering price of the Shares being offered herein has been arbitrarily determined by us and bears no relationship to any criteria of value; as such, investors should not consider the offering price or value to be an indication of the value of the shares being registered.**</u>

Currently, there is a limited public market for our Shares. The offering price for the Shares being registered in this offering has been arbitrarily determined by us and is not based on assets, operations, book or other established criteria of value. Thus, investors should be aware that the offering price does not reflect the market price or value of our common shares.

<u>**We may, in the future, issue additional shares of Common Stock, which would reduce the investor' percentage of ownership and may dilute our share value.**</u>

Our Articles of Incorporation authorize the issuance of 25,000,000,000 shares of Common Stock; up to 5,000,000 shares of Preferred Stock. As of January 31, 2025, the Company has 16,812,001,513 shares of Common Stock, and As of the date of this offering, there are 2,000,000 PREFERRED SERIES A (super voting only) and 272,000 PREFERRED SERIES B (convertible) shares have been issued and outstanding. If we sell the entire 2,900,000,000 shares of Common Stock in this Offering, we will have 19,712,001,513 shares of Common Stock issued and outstanding. Accordingly, we may issue additional shares of Common Stock at a later date to employees or for services. The future issuance of common stock may result in substantial dilution in the percentage of our common stock held by our then existing shareholders. We may value any common stock issued in the future on an arbitrary basis. The issuance of common stock for future services or acquisitions or other corporate actions may have the effect of diluting the value of the shares held by our investors, and might have an adverse effect on any trading market for our common stock.

<u>**The VOTING RIGHTS OF COMMON & PREFERRED SHARES restrict the ability of shareholders to have any significant control as a results of their shares**</u>

There are two classes of PREFERRED SHARES, A and B, and one class of COMMON SHARES. Each of these classes effects the voting control of the Company now and in the foreseeable future.

* PREFERRED SERIES A - Vote as Common Shares at the ratio of one PREFERRED SERIES A share equals 5,000 Common Shares.
These shares are designated as non-convertible, therefore they act solely as a voting control class of shares only. Each SERIES A Preferred Share votes at 1:5,000 to Common Stock. Therefore this represents majority voting control of the Company.

* PREFERRED SERIES B - PREFERRED SERIES B Shares are convertible to Common Shares, at the shareholders discretion, at 50% of 5-day trading average prior to conversion. When converted, these common shares have the same voting rights as others in the same class of securities. The PREFERRED SERIES B Shares do not have specific voting rights prior to conversion into Common Shares.

* COMMON SHARES - Common Shares vote one vote per share. The three directors and their associated corporate entities, control Collectively they own 9,928,500,000 Common Shares out of the 16,812,001,513 Issued and Outstanding. This represents 59% of the Common Shares. SEE ALSO CONTROLLING SHAREHOLDERS below.

* CONTROLLING SHAREHOLDERS - Voting control of the company is held by three parties as a whole. Each of these parties are also the three board members and both board seats. Collectively they own 9,928,500,000 Common Shares out of the 16,812,001,513 Issued and Outstanding before the sale, and a further 10,000,000,000 (ten billion) votes due to the ownership of all of the PREFERRED SERIES A shares. This represents a majority voting control both free and post offering, assuming the sale of all 4,900,000,000 new shares included in this registration. The rights and amounts are described in detail in ITEM 12. SECURITY OWNERSHIP OF MANAGEMENT AND CERTAIN SECURITY HOLDERS on Page 20.

SUMMARY: The combined voting control means that the Management controls the majority votes both before and following this offering, even if all newly registered shares are sold. The Management and the Officers and Directors who have this voting control are therefore free to make changes to the direction of the Company without further shareholder consent.

------

 <u>**The Company, by determination of the Board of Directors, in its sole discretion, may issue the Securities under this Offering for cash, promissory notes, services, and/or other consideration without notice to subscribers.**</u>

From time to time the Company may issue shares for non-cash services. If such an issuance is made it will be done in order to maintain our cash position. As required by SEC regulations, the Company will value any non-cash consideration according to the Note to Rule 251(a)(1) of Regulation A.

 <u>**We are publicly traded company and we may finance our business through debt at a future date**</u>

As with other public companies, we may choose, from time to time, to finance our business through the sale of stock or promissory notes collateralized by our common stock We may also acquire debt in the form of mezzanine or bridge financing. We may borrow such funds from a traditional bank, or non-bank third party. We hope to finance acquisitions mostly with the sale of our common stock in this offering. As a result, our balance sheet may be unduly leveraged and if we cannot sell or liquidate our opportunities, we will be burdened by debt service, including, but not limited to payment of principal and interest and other fees.

<u>**We are subject to compliance with securities law, which exposes us to potential liabilities, including potential rescission rights.**</u>

We may offer to sell our common stock to investors pursuant to certain exemptions from the registration requirements of the Securities Act of 1933, as well as those of various state securities laws. The basis for relying on such exemptions is factual; that is, the applicability of such exemptions depends upon our conduct and that of those persons contacting prospective investors and making the offering. We may not seek any legal opinion to the effect that any such offering would be exempt from registration under any federal or state law. Instead, we may elect to rely upon the operative facts as the basis for such exemption, including information provided by investor themselves.

If any such offering did not qualify for such exemption, an investor would have the right to rescind its purchase of the securities if it so desired. It is possible that if an investor should seek rescission, such investor would succeed. A similar situation prevails under state law in those states where the securities may be offered without registration in reliance on the partial preemption from the registration or qualification provisions of such state statutes under the National Securities Markets Improvement Act of 1996. If investors were successful in seeking rescission, we would face severe financial demands that could adversely affect our business and operations. Additionally, if we did not in fact qualify for the exemptions upon which it has relied, we may become subject to significant fines and penalties imposed by the SEC and state securities agencies.

------

 **ITEM 4. DILUTION**

If you invest in our shares, your interest will be diluted to the extent of the difference between the offering price per share of our common stock in this offering and the as adjusted net tangible book value per share of our capital stock after this Offering. The following table demonstrates the dilution that new investors will experience relative to the Company' net tangible book value as of January 31, 2025,. Net tangible book value is the aggregate amount of the Company' tangible assets, less its total liabilities. The table presents three scenarios: a $262,500 raise from this Offering, a $525,000 raise from this Offering and a fully subscribed $1,050,000 million raise from this Offering.

---

| | | | |
|:---|:---|:---|:---|
| **Proceeds from Sale**  | **$183750**  | **$367500**  | **$735000**  |
| Percentage of Shares Sold  | 25%  | 50%  | 100%  |
| Price Per Share  | $0.00015 | $0.00015 | $0.00015 |
| Shares Issued  | 1225000000 | 2450000000 | 4900000000 |
| Capital Raised  | 183750 | 367500 | 735000 |
| Less Offering Costs  | 50000 | 50000 | 50000 |
| Net Proceeds  | 133750 | 317500 | 685000 |
| Net Tangible Value Pre-Financing  | (273748) | (273748) | (273748) |
| Net Tangible Value Post-Financing  | (214998) | (106248) | 161252 |
| Shares Issued and Outstanding - Pre Financing  | 16812001513 | 16812001513 | 16812001513 |
| Shares Issued and Outstanding - Post Financing  | 18037001513 | 19262001513 | 21712001513 |
| Net Tangible Value Pre-Financing  | $0.000016 | $0.000016 | $0.000016 |
| Increase/Decrease per Share Attributable To New Investors  | ($0.0000006) | ($0.0000142) | $0.000001 |
| Net Tangible Book Value per Share, Post Offering  | $0.000010 | $0.00000021 | $0.000017 |

---

Another important way of looking at dilution is the dilution that happens due to future actions by the company. The investor' stake in a company could be diluted due to the company issuing additional shares. In other words, when the company issues more shares, the percentage of the company that you own will go down, even though the value of the company may go up. You will own a smaller piece of a larger company. This increase in number of shares outstanding could result from a stock offering (such as an initial public offering, a venture capital round, angel investment), employees exercising stock options, or by conversion of certain instruments (e.g. convertible bonds, convertible notes, preferred shares or warrants) into stock. If the company decides to issue more shares, an investor could experience value dilution, with each share being worth less than before, and control dilution, with the total percentage an investor owns being less than before.

The company has authorized and issued Common stock and two classes of Preferred Stock. Therefore, all of the company' current shareholders and the investors in this Offering will experience the same dilution if the company decides to issue more shares in the future.

**NOTE:** As of the date of this offering, there are 2,000,000 PREFERRED SERIES A (super voting only) and 272,000 PREFERRED SERIES B (convertible) shares have been issued.

------

 **ITEM 5. PLAN OF DISTRIBUTION** 

We are offering a maximum of Seven Billion (7,000,000,000) Shares of Common Stock Including Two Billion one hundred million (2,100,000,000) from selling shareholders and; One hundred thousand PREFERRED SERIES B (100,000) convertible shares from a selling shareholder. Four Billion one hundred million (4,900,000,000) Common Shares are being sold by the Company and are newly issued for that purpose. There is a minimum investment of $15,000 (100,000,000 Shares) on a best efforts basis. The Minimum Investment, per investor, may be waived at the Management's discretion.

We will sell the shares ourselves and do not plan to use underwriters or pay any commissions. We will be selling our shares using our best efforts and no one has agreed to buy any of our shares. This prospectus permits our existing, and future, officers and directors to sell the shares directly to the public, with no commission or other remuneration payable to them for any shares they may sell. There is currently no plan or arrangement to enter into any contracts or agreements to sell the shares with a broker or dealer. Our officers and directors will sell the shares and intend to offer them to friends, family members and business acquaintances. There is no minimum amount of shares we must sell; so no money raised from the sale of our shares will go into escrow, trust or another similar arrangement.

The shares are being offered by the Company. The Company will be relying on the safe harbor in Rule 3a4-1 of the Securities Exchange Act of 1934 to sell the shares. No sales commission will be paid for shares sold by the Company. None of our Officer and Directors are subject to a statutory disqualification and are not associated persons of a broker or dealer.

Additionally, our Officer and Directors perform substantial duties on behalf of the registrant other than in connection with transactions in securities. None has not been a broker or dealer or an associated person of a broker or dealer within the preceding 12 months and they have not participated in selling an offering of securities for any issuer more than once every 12 months other than in reliance on paragraph (a)4(i) or (a)4(iii) of Rule 3a4-1 of the Securities Exchange Act of 1934.

The offering will terminate upon the earlier to occur of: (i) the sale of all 2,900,000,000 shares being offered, or (ii) 365 days after this Offering Circular is declared qualified by the Securities and Exchange Commission or (iii) or the decision by Company management to deem the offering closed.

 **<u>Selling Shareholders - holdings before and after</u>**

The following table sets forth information about the selling shareholders and their respective share holdings before and following the sale of the registered portion of their shares. <br>

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | Capacities in which  | Shares held  | Shares held  | Shares  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Name  | Position in Company  | Before Offering  | After Offering  | Sold  |
| Hamon Francis Fytton | CEO, Director | 3,309,500,000 COMMON | 2,609,500,000 COMMON | 700,000,000 COMMON |
| Cathy Julian  | Chief Financial Officer & Director | 3,309,500,000 COMMON | 2,609,500,000 COMMON | 700,000,000 COMMON |
| James Kander | Director & Ice Lounge Media shareholder | 3,309,500,000 COMMON  | 2,609,500,000 COMMON | 700,000,000 COMMON |
| Devon Medical Products c/o John Bennett  | Compensation for the sale of Devon | 100,000 PREFERRED SERIES B  | -0-  | 100,000 PREFERRED SERIES B  |

---

Only the Officers and Directors of the selling shareholders are facilitating sales of the common shares in the primary, best efforts offering. <br>Purchasers of any of these shares will determine whether any sale of common shares is for the benefit of the company or for the accounts of the selling shareholders by the following. <br>Investors will know they are purchasing shares directly from the company by virtue of the fact they would be required to complete a Share Purchase Agreement between them and the company. <br>Shares sold by selling shareholders would typically be sold into the public float or by private sales between the purchaser and selling shareholder. The Company will not receive any proceeds from sales by the Selling Shareholders.

There are an additional 2,100,000,000 shares of Common Stock being offered and a further one hundred thousand PREFERRED SERIES B (100,000) convertible shares by the Selling Shareholders. The Company will not receive any proceeds from sales by the Selling Shareholders.

------

**ITEM 6. USE OF PROCEEDS TO ISSUER**

We estimate that, at a per share price of $0.0015, the net proceeds from the sale of the 2,900,000,000 shares in this Offering will be approximately $385,000, after deducting the estimated offering expenses of approximately $50,000.

 <u>**Purpose of Offering**</u>

***We will utilize the net proceeds from this offering to identify and acquire business opportunities and to develop our products. Some funds will be used for operating expenses and other expenses.***

***We have made allowance for the expenses to file and become an SEC Reporting Company, and therefore be required to file reports periodically with the Securities and Exchange Commission under section 12, 13 or 15(d) of the Securities Exchange Act of 1934.***

***Accordingly, we expect to use the net proceeds, estimated as discussed above as follows, if we raise the maximum offering amount:***

 **TABLE Use Of Proceeds at 25%, 50% and 100%**

---

| | | | |
|:---|:---|:---|:---|
| **Proceeds from Sale**  | gg **$183,750**  | **$367500**  | **$735000**  |
| Percentage of Shares Sold  | 25%  | 50%  | 100%  |
| Less Offering Costs  | 50000  | 50000  | 50000  |
| Net Proceeds  | <u>133750</u> | <u>317500</u> | <u>685000</u> |
| Acquisition Costs  | 60000 | 100000 | 350000 |
| Accounting, Audit & Legal fees  | 25000 | 25000 | 50000 |
| Working Capital  | 23750 | 67500 | 160000 |
| Salaries  | 25000 | 75000 | 125000 |
| <u>TOTAL</u>  | <u>$183750</u> | <u>$367500</u> | <u>$735000</u> |

---

(1) *"Acquisition Costs"* are costs related to the selection and acquisition of opportunities, including financing and closing costs. These expenses include but are not limited to travel and communications expenses, legal and accounting fees and miscellaneous expenses. The presentation in the table is based on the assumption that we will always finance the acquisition of opportunities whenever posable. NOTE: at 25% there is insufficient proceeds for an Acquisition, so Costs and Salaries are NIL.

(2) *Offering Expenses*include projected costs for Legal and Accounting, Publishing/Edgar and Transfer Agents Fees.

The above figures represent only estimated costs. This expected use of net proceeds from this offering represents our intentions based upon our current plans and business conditions. The amounts and timing of our actual expenditures may vary significantly depending on numerous factors, including the status of and results from operations. As a result, our management will retain broad discretion over the allocation of the net proceeds from this offering. We may find it necessary or advisable to use the net proceeds from this offering for other purposes, and we will have broad discretion in the application of net proceeds from this offering. Furthermore, we anticipate that we will need to secure additional funding for the fully implement our business plan.

**The company reserves the right to change the above use of proceeds if management believes it is in the best interests of the company.** 

------

 **ITEM 7. DESCRIPTION OF BUSINESS** 

<u>**Our Company**</u>

The Company has recently expanded its healthcare operations with a 20% ownership in MEDWORX A INC, a medical billing company, during the first quarter of 2024.. Upon completion of this offering, and following a successful capital raise, the Company intends to seek other acquisitions in the healthcare industry. The timing of commencement of expanding operations may be influenced by our relative success of this offering. We may not raise sufficient proceeds through this offering in order to fully execute our business plans.

The Company does not propose to restrict its search for a business opportunity to any particular industry or geographical area and may, therefore, engage in essentially any business in any industry. The Company has unrestricted discretion in seeking and participating in a business opportunity, subject to the availability of such opportunities, economic conditions, and other factors. The selection of a business opportunity in which to participate is complex and risky. Additionally, as the Company has only limited resources and may find it difficult to locate good opportunities. There can be no assurance that the Company will be able to identify and acquire any business opportunity which will ultimately prove to be beneficial to the Company and its shareholders. The Company will select any potential business opportunity based on management' business judgment. The activities of the Company are subject to several significant risks, which arise primarily as a result of the fact that we have no specific business, and may acquire or participate in a business opportunity based on the decision of management, which potentially could act without the consent, vote, or approval of the Company' shareholders.

 <u>**Business Information**</u>

<u>**Introduction**</u>

Gold Entertainment Group, Inc. is a Medical Device distributor. The Company signed an agreement on December 31, 2022, to acquire 51% of Devon Orthopedic Implants, LLC ("ORTHO") a Delaware limited liability company with offices in New Port Richey, Florida. ORTHO is an operating company and operates as a subsidiary of GOLD effective January 31, 2023. The other 49% ownership is EXLITES HOLDINGS INTERNATIONAL INC. a New Mexico corporation with a public trading symbol of EXHI. The Company issued 100,000 PREFERRED SERIES B to Devon Medical Products as payment. (see table in ITEM 12. SECURITY OWNERSHIP OF MANAGEMENT AND CERTAIN SECURITY HOLDERS). These shares are convertible to Common Shares with a 50% discount to the current traded price, at the sold discretion of the shareholder. These shares are included in this offering for registration.

The Company has recently expanded its healthcare operations with a 20% ownership in MEDWORX A INC, a medical billing company, during the first quarter of 2024. The Company issued the sum THREE BILLION FIVE HUNDRED THOUSAND (3,500,000,000) Shares of GEGP's Common Stock to MEDIWORX's shareholders or their assignees, for the purchase of TWENTY PERCENT (20%) of MEDIWORXS's Common Shares or equivalent LLC membership interests) ; and (ii) that GEGP's Management shall perform a registration of the Common Stock as supplied to MEDIWORX's shareholders on the terms and subject to the conditions set forth in the attached agreement EXHIBIT 10.1.

Both of these agreements are attached as separate EXHIBITS 10.1 & 10.2.

We expect to use substantially all of the net proceeds from this offering to engage in the acquisition of existing businesses and becoming an SEC reporting Company. We expect to build a high-quality brand portfolio intended to generate income and to provide capital preservation, capital appreciation and portfolio diversification. These opportunities may be existing opportunities, new opportunities which we intend to acquire, make business improvements and provide financing for business expansion. We intend to conduct our operations so that neither we nor, our subsidiaries are required to register as an investment company under the Investment Company Act of 1940, as amended, or the 1940 Act.

We are not engaged primarily, nor do we propose to engage primarily, in the business of investing, reinvesting, or trading in securities. We are likewise not engaged, and do not propose to engage, in the business of investing, reinvesting, owning, holding, or trading in securities. We expect to acquire a controlling interest in, and operate, several different businesses. After acquiring controlling interests in these companies we will not be trading in their securities. Instead, we will be actively managing these businesses and seeking to grow these businesses over time. Unlike an investment company, we will only hold controlling interests in our subsidiaries and we will actively manage the business and growth of our subsidiaries. <br> As disclosed in our Registration Statement, as amended, our business plan involves the acquisition and management of a group of small businesses that will become our subsidiaries and that we will operate and grow over time.

 **<u>Detailed explanation of existing business operations that generated the $559,545 in revenue.</u>** <br>Financial Data Supporting Response<br> FY 2025 Revenue: $559,545<br> FY 2024 Revenue:$524,811<br> Current Operations: 51% ownership of Devon Orthopedic Implants, LLC<br>Current Operating Business Medical Device Distribution (added to ITEM 7 Description of Business PAGE 18) <br> The Company currently operates as a medical device distributor primarily through its 51% owned subsidiary, Devon Orthopedic Implants, LLC ("Devon Ortho"), acquired effective January 31, 2023. Devon Ortho is an active operating company with facilities in New Port Richey, Florida. Revenue Generation and Business Model: For the fiscal year ended January 31, 2025, the Company generated net sales of $559,545, representing a 6.6% increase from $524,811 in fiscal 2024. This revenue was generated through: <br>1. Wholesale Distribution:Sale of orthopedic implants, surgical instruments, and related medical devices to: <br>Hospitals and surgery centers<br> Orthopedic medical practices<br> Ambulatory surgical centers<br> Healthcare systems<br>2. Product Lines: Distribution of orthopedic products including joint replacement systems, trauma implants, and surgical instruments from established medical device manufacturers. <br>3. Geographic Coverage: Serving healthcare providers primarily in Florida and surrounding southeastern markets. <br>4. Value-Added Services: Inventory management, technical support, and product training for healthcare professionals. <br>Operational Infrastructure: - 19 full-time employees across healthcare operations - Established distribution facility and inventory management systems - Regulatory compliance programs for medical device distribution - Customer service and technical support capabilities <br>This demonstrates the Company has a specific, active business plan centered on medical device distribution with established revenue streams, rather than being a development stage company seeking unidentified acquisition targets. <br>

Our disclosure is not consistent with being an investment company. To the contrary, our disclosure statement emphasizes the fact that we intend to acquire controlling interests in businesses that we will actively manage and grow over time.

In light of the foregoing, we believe that we satisfy the historical development and public representations of policy tests and should not be considered an investment company under Section 3(b)(1).

<u>**Our Competitive Strengths**</u>

We believe that The Company will be able to attract experienced directors and officers and other key personal with the necessary experience. We believe our investment strategy will assist in their recruitment, and distinguish us from other brand development companies. Specifically, our competitive strengths include the following:

---

| |
|:---|
| *<u>Experienced and Dedicated Management</u>.* The Company intends to recruit a committed management team with experience in various business projects. This team, who in place, will assist in establishing a robust infrastructure of service providers, including financial and business development managers for assets under management.<br>|
| *<u>Investing Strategy</u>*. Our Management has an extensive deal flow network in various markets due to long-standing relationships with business owners and public company lenders.<br>|
| *<u>Highly Disciplined Investing Approach</u>*. We intend to take a time-tested and thorough approach to analysis, management and investor reporting.  |

---

<u>**Market Opportunity**</u>

The economic outlook, in our view, presents an opportunity for our business. The Company believes that recent corrections in the national, regional and local markets are healthy and, in many cases, overdue. Over the course of the past several months, the Company have noticed that consumers have begun to explore the development of market-appropriate product with realistic absorption projections and expectations of realizable upside upon completion of their project in one to three years. Many businesses are experiencing a critical lack of investment capital. The contraction in capital supply to the small to mid-sized business has not only added to the potential acquition base for the Company but also is expected to produce higher credit borrowers and enhanced the Company' investment power. As a result of tight lending rules, outside of SBA incentives, many smaller business operators, of all types, become more favorable to the concept of acquisition by a public company, combined with financing.

------

 <u>**Investment Objectives**</u>

Our primary investment objectives are:

- to maximize the capital gains of our opportunities;

- to preserve and protect your capital contribution; 

- to enable investors to realize a return on their investment by beginning the process of liquidating and distributing cash to investors within approximately five years of the termination of this offering, or providing liquidity through alternative means such as in-kind distributions of our own securities or other assets; and

- To achieve long-term capital appreciation for our stockholders through increases in the value of our company.

We will also seek to realize growth in the value of our investments and to optimize the timing of their expansion.

However, we cannot assure you that we will attain these objectives or that the value of our investments will not decrease. We have not established a specific policy regarding the relative priority of these investment objectives.

<u>**Investment Policies**</u>

Our investment objectives are to maximize the capital gains of our opportunities and achieve long-term capital appreciation for our stockholders through increases in the value of our company. We have not established a specific policy regarding the relative priority of these investment objectives.

We expect to pursue our investment objectives primarily through the ownership of businesses, of various types, and with tangible assets. We currently intend to invest primarily in the acquisition, development and management of existing businesses, instead of developing our own. While we may diversify in terms of business types , we do not have any limit on the amount or percentage of our assets that may be invested in any type of business, or any one geographic area.

We may also participate with third parties in business ownership, through joint ventures or other types of co-ownership. These types of investments may permit us to own interests in larger assets without unduly restricting our diversification and, therefore, provide us with flexibility in structuring our portfolio. We will not, however, enter into a joint venture or other partnership arrangement to make an investment that would not otherwise meet our investment policies.

Any Business Investments contemplated by our Company, are also subject to our policy not to be treated as an investment company under the Investment Company Act of 1940, as amended, or the 1940 Act.

THE COMPANY HAS NOT PREVIOUSLY, AND WILL NOT, ENGAGE IN ANY ACQUISITION THAT WOULD MAKE IT LIABLE TO, OR BE BE SUBJECT TO AN INVESTMENT COMPANY ACT OF 1940 REGISTRATION.

------

<u>**Acquisition of opportunities**</u>

The Company intends on acquiring businesses primarily through industry contacts, including debt financiers who may have distressed businesses that they would be willing to transfer to our management. The number of businesses opportunities that may be available from all of the foregoing sources will vary from time to time, depending on numerous factors including, without limitation, trends in delinquent debt and capital availability.

<u>**Tax Treatment of Registrant and its Security Holders.**</u>

We are a publicly traded company and investment typically takes the form of Common Stock as the final delivered asset. Therefore, we operate a, C corporation. As such, our profits are taxable at corporate level and dividends, if any, are taxable at individual level. These are typically taxed as a capital gain or dividend.

<u>**Competition**</u>

The business acquisition market is highly competitive. We will compete based on a number of factors that including experienced management and capital availability. As a public company, the Common Stock as a viable financial exit is attractive to business owners.

------

We will compete with many third parties engaged in investment activities including REITs, specialty finance companies, hedge funds, investment banking firms, lenders and other entities. Some of these competitors have substantially greater marketing and financial resources than we will have and generally may be able to accept or manage more risk than we can prudently manage, including risks with respect to the businesses being acquired. In addition, these same entities may seek financing through the same channels that we do. Therefore, we will compete for investors and funding in a market where funds for business investment may decrease, or grow less than the underlying demand.

Competition may limit the number of suitable investment opportunities offered to us and result in higher prices, making it more difficult for us to acquire new investments on attractive terms. In addition, competition for desirable investments could delay the investment of net proceeds from this offering in desirable assets, which may in turn reduce our cash flow from operations and negatively affect our ability to make or maintain distributions.

<u>**Government Regulation**</u>

Our business is subject to many laws and governmental regulations. Changes in these laws and regulations, or their interpretation by agencies and courts, occur frequently.

<u>**Investment Company Act of 1940**</u>

We intend to conduct our operations so that we are not required to register as an investment company under the Investment Company Act of 1940, as amended, or the 1940 Act.

Our investment objectives are to maximize the capital gains of our opportunities and achieve long-term capital appreciation for our stockholders through increases in the value of our company. We have not established a specific policy regarding the relative priority of these investment objectives. We expect to pursue our investment objectives primarily through the ownership of businesses, of various types, and with tangible assets. We currently intend to invest primarily in the acquisition, development and management of existing businesses, instead of developing our own. While we may diversify in terms of business types , we do not have any limit on the amount or percentage of our assets that may be invested in any type of business, or any one geographic area. We may also participate with third parties in business ownership, through joint ventures or other types of co-ownership. These types of investments may permit us to own interests in larger assets without unduly restricting our diversification and, therefore, provide us with flexibility in structuring our portfolio. We will not, however, enter into a joint venture or other partnership arrangement to make an investment that would not otherwise meet our investment policies. Any Business Investments contemplated by our Company, are also subject to our policy not to be treated as an investment company under the Investment Company Act of 1940, as amended, or the 1940 Act. <br>THE COMPANY HAS NOT PREVIOUSLY, AND WILL NOT, ENGAGE IN ANY ACQUISITION THAT WOULD MAKE IT LIABLE TO, OR BE BE SUBJECT TO AN INVESTMENT COMPANY ACT OF 1940 REGISTRATION.

<u>**Environmental Matters**</u>

Many environmental regulations require specific zoning and environmental regulations at the State, local and Federal level. The Company may be held liable under these regulations when making acquisitions. These laws and liabilities may be extended to the Company' employees.

Under various federal, state and local laws, ordinances and regulations, a current or previous owner or operator of real property may be held liable for the costs of removing or remediating hazardous or toxic substances. These laws often impose clean-up responsibility and liability without regard to whether the owner or operator was responsible for, or even knew of, the presence of the hazardous or toxic substances. The costs of investigating, removing or remediating these substances may be substantial, and the presence of these substances may adversely affect our ability to rent or sell the property or to borrow using the property as collateral and may expose us to liability resulting from any release of or exposure to these substances. If we arrange for the disposal or treatment of hazardous or toxic substances at another location, we may be liable for the costs of removing or remediating these substances at the disposal or treatment facility, whether or not the facility is owned or operated by us. We may be subject to common law claims by third parties based on damages and costs resulting from environmental contamination emanating from a site that we own or operate. Certain environmental laws also impose liability in connection with the handling of or exposure to asbestos-containing materials, pursuant to which third parties may seek recovery from owners or operators of real opportunities for personal injury associated with asbestos-containing materials and other hazardous or toxic substances.

The Company may avoid the acquisition of businesses that are subject to specific environmental regulations for the reasons stated above.

------

 <u>**Other Regulations**</u>

The opportunities we acquire likely will be subject to various federal, state and local regulatory requirements, such as zoning and state and local fire and life safety requirements. Failure to comply with these requirements could result in the imposition of fines by governmental authorities or awards of damages to private litigants. We generally will acquire opportunities that are in material compliance with all regulatory requirements. However, there can be no assurance that these requirements will not be changed or that new requirements will not be imposed which would require significant unanticipated expenditures by us and could have an adverse effect on our financial condition and results of operations.

<u>**Employees:**</u>

Currently, the company has 19 full time employees in the various healthcare operations. The company may hire an additional number of employees as needed after effectiveness of this offering primarily to support our acquisition and development efforts.

<u>**Legal Proceedings**</u>

We know of no existing or pending legal proceedings against us, nor are we involved as a plaintiff in any proceeding or pending litigation. There are no proceedings in which any of our directors, officers or any of their respective affiliates, or any beneficial stockholder, is an adverse party or has a material interest adverse to our interest.

**ITEM 8. DESCRIPTION OF PROPERTY** 

Our principal offices are located at 2412 Irwin St. Melbourne, FL 32901 The office is provided by our CEO at no cost to the Company. Additionally we have a distribution location at 16034 us hwy 19, Hudson FL 34667. This building has a related party ownership to our CFO, Cathy Julian. The office is provided by our CFO at no cost to the Company. We do not currently lease or own any other real property.

------

 **ITEM 9. MANAGEMENTS DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS** 

The company was incorporated in State of Nevada on February 3, 1999 under the name ADVANCED MEDICAL TECHNOLOGIES INC. / CANADA. The name was changed to Gold Entertainment Group, Inc. in April 2002. The fiscal year end is January 31st. Our principal executive offices are located at 2412 Irwin St., Melbourne, FL 32901

Gold Entertainment Group, Inc. is a Medical Device distributor. The Company signed an agreement on December 31, 2022, to acquire 51% of Devon Orthopedic Implants, LLC ("ORTHO") a Delaware limited liability company with offices in New Port Richey, Florida. ORTHO is an operating company and operates as a subsidiary of GOLD effective January 31, 2023. The other 49% ownership is EXLITES HOLDINGS INTERNATIONAL INC. a New Mexico corporation with a public trading symbol of EXHI. The Company has recently expanded its healthcare operations with a 20% ownership in MEDWORX A INC, a medical billing company, during the first quarter of 2024.

We expect to use substantially all of the net proceeds from this offering to engage in the acquisition of existing businesses and becoming an SEC reporting Company. We expect to build a high-quality brand portfolio intended to generate income and to provide capital preservation, capital appreciation and portfolio diversification. These opportunities may be existing opportunities, new opportunities which we intend to acquire, make business improvements and provide financing for business expansion. We intend to conduct our operations so that neither we nor, our subsidiaries are required to register as an investment company under the Investment Company Act of 1940, as amended, or the 1940 Act.

We expect to use substantially all of the net proceeds from this offering to engage in the acquisition of existing businesses and develop their business operations and brands. We expect to build a high-quality brand portfolio intended to generate current income and to provide capital preservation, capital appreciation and portfolio diversification. The opportunities may be existing businesses, or new opportunities for which we intend to acquire, make business improvements and provide additional capital.

We have been utilizing and may continue to utilize funds from Mr. Fytton our CEO, who has informally agreed to advance funds to allow us to pay for offering costs, filing fees, and professional fees. Mr. Fytton however, has no formal commitment, arrangement or legal obligation to advance or loan funds to the company. In order to implement our plan of operations for the next twelve-month period, we require approximately $50,000 of funding from this offering. After a twelve-month period, we may need additional financing, depending on the capital needs of the acquisitions, but currently do not have any arrangements for such financing.

For the next twelve months we anticipate that we will need up to $1 million in operational funds to carry out the acquisition and development of opportunities, The Company may select different companies, geographic locations as and when funds become available, therefore, we may need 1-2 months to evaluate specific locations. For all business purposes if we are short of funds we may request funds from our Chief Executive Officer, however, there is no guarantee he will loan us funds.

The company has contacted institutions about financing loans for our Company. We will only use such funds when we feel we have both located a target acquisition, and the Company has capital sufficient to complete the acquisition.

Generally, it is known to be a common fact that banks, credit unions, and other comparable institutions may not provide financing to a Company without substantial assets, revenue and/or personal asset guarantees. Because of this we may face difficulty in acquiring financing for our target opportunities or funds necessary to provide the marketing and administration funds for business expansion, including acquisitions. We are therefore dependent upon our ability to attract private investment that may include financing through convertible debentures or loans. This may cause investors to lose some or all of your investment, due to the debt being converted and the common stock of the Company diluted..

Once the Company locates a suitable acquisition, we will determine the funds required to complete the project. The amount of funds allocated for this may vary and will depend on the target company and their capital needs.

Long term financing and commitments will be required to fully implement our business plan. The Company will always be dependent on outside funding for the full implementation of our business plan. Our expansion may include expanding our office facilities, hiring personnel and developing a larger customer base.

If we do not receive adequate proceeds from this offering to carry out our forecasted operations to operate for the next 12 months our CEO Mr. Fytton, has informally agreed to provide us funds, however, he has no formal commitment, arrangement or legal obligation to provide funds to the company.

If we need additional cash and cannot raise it, we will either have to suspend operations until we do raise the cash we need, or cease operations entirely.

We intend to conduct our operations so that neither we nor any of our subsidiaries are required to register as an investment company under the Investment Company Act of 1940, as amended, or the 1940 Act.

------

**POLICY WITH RESPECT TO CERTAIN ACTIVITIES** 

(a) We do not plan to issue any new shares of Common Stock outside of this Offering. Notwithstanding we may issue new shares to employees, independent contractors or acquisition targets.. Our Board of Directors may change our policy regarding the issuance of preferred shares at any time and in their discretion and without a vote of security holders.

(b) We do plan to borrow money from private secured lenders to make acquisitions and finance business activities, but will not do so unless this offering is successful. Our business plan involves obtaining financing through the sale of Common Stock. Our Management may change our policy regarding borrowing money at any time and without a vote of security holders.

(c) We have not and do not have any plans to make loans to other businesses. Our Management may change our policy regarding plans to make loans to other persons or entities in their discretion at any time and without a vote of security holders.

(d) We have not and do not have any plans to invest in the securities of other issuers for the purpose of exercising control. Our Management may change our policy regarding plans to make loans to other persons or entities in their discretion at any time and without a vote of security holders.

(e) We have not and do not have any plans to underwrite securities of other issuers. Our Management may change our policy regarding plans to underwrite securities of other issuers in their discretion at any time and without a vote of security holders.

(f) We have not and do not have any plans to engage in the purchase and sale (or turnover) of investments. Our Management may change our policy regarding plans to engage in the purchase and sale (or turnover) of investments at any time and without a vote of security holders.

(g) We have not and do not have any plans to offer securities in exchange for services. Our Management may change our policy regarding plans to offer securities in exchange for services at any time and without a vote of security holders.

(h) We have not and do not have any plans to repurchase or otherwise reacquire its shares or other securities. Our Management may change our policy regarding plans to repurchase or otherwise reacquire its shares or other securities at any time and without a vote of security holders.

(i) We do intend to make quarterly and annual or other reports to security holders in the future, although we have not concluded the nature, content and scope of such reports at this time and such reports may contain financial statements certified by independent public accountants. These reports may be required by agencies such as the SEC and FINRA as well as quotation systems and stock exchanges. Our Management may change or eliminate our policy regarding plans to make quarterly and annual reports available to security holders including the content at any time and without a vote of security holders.

------

**INVESTMENT POLICIES OF REGISTRANT** 

1. We plan to focus our on business acquisition. Where these businesses own real estate as part of their assets, we will evaluate the value assigned to the real estate portion of the business separately. The Company may expand our operations to acquire and lease real estate in states as part of our operations. Our Management may change our existing policy regarding target businesses at any time and without a vote of security holders. We may invest some of our assets in the purchase of real estate, where such purchases involve our business operations.

2. We may invest in any type of business including but not limited to existing businesses and special purpose buildings.

3. To support the market for its public stock, we plan on commencing an extensive investor relations program. We may also use a (to be identified) online funding platform to sell shares pursuant to this offering but have no definitive plans to do so.

4. We believe that our CEO and other management has the necessary experience and industry contacts to carry out our business plan.

5. Our policy is to acquire assets primarily for income and not capital gain. Our Management may change our existing policy regarding our method of operating and financing of acquisitions at any time and without a vote of security holders.

6. We do not have a policy that restricts us to the amount or percentage of assets which will be invested in any specific business.

7. We do not have any other material policy with respect to our proposed acquisition activities.

8. Investments in other securities.

We do not have any policy or plans at this time to invest in any other types of securities. Our Management may change our existing plan regarding an investment in any other securities at any time and without a vote of security holders.

Since its inception, the Company has devoted substantially all of its efforts to business planning, research and development, recruiting management and staff and raising capital. Accordingly, the Company is considered to be in the development stage, since we are devoting substantially all of our efforts to establishing our business and planned principal operations have not commenced. The Company has generated minimal revenues from operations and therefore lacks meaningful capital reserves.

------

**Plan of Operations** 

Over the next twelve months, the Company intends to focus on acquiring businesses using the proceeds from this offering. Our officers and directors will meet with businesses owners, brokers, consultants and advisors in the finance industry to locate opportunities which meet the Company' profile. We may engage other consultants to conduct initial due diligence with respect to opportunities which may be of interest to the Company.

IceLounge has a network that includes a businesses owners, and believes that by utilizing this network, they will be able to identify appropriate opportunities. We plan to purchase these opportunities through the sale of the Company' Common Stock and debt financing. We may also acquire debt in the form of mezzanine or bridge financing. However, we hope to limit our financing costs and our financing to direct leverage of the business asset being acquired. We hope to finance acquisition costs mostly with the sale of our Common Stock in this offering.

 **Operating Results**

 **Year analysis for the years ending January 31, 2024 and January 31, 2023**

We had a net loss of $51,608 for the twelve months ended January 31, 2024 compared to a net loss of $62,119 for the twelve months ended January 31, 2023. Expenses of operation were $75,608 for the twelve months ended January 31, 2024 as compared to $62,119 for the year ended January 31, 2023.

 **Quarterly analysis for the period ending October 31, 2024 and October 31, 2023**

We had a net loss of ($20,321) for the six months ended October 31, 2024 compared to a net loss of ($21,931) for the six months ended October 31, 2023. Expenses of operation were $72,175 for the three months ended October 31, 2024 as compared to $49,963 for the six months ended October 31, 2023.

 **Liquidity and Capital Resources for the year ending January 31, 2024 and January 31, 2023**

Cash flows used by operating activities for the year ending January 31, 2024 were $(9,122) compared to cash used of $52,114) for the year ended January 31, 2023. The increase comparing those two periods was primarily due to a major change in operations. Cash flows used in investing activities were $203,141 and $(0) for the period ended January 31, 2024 and 2023, respectively. Cash flows gained from financing activities for the year ended January 31, 2024, were $152,898 compared to $(0) for the year ended January 31, 2023.

 **Liquidity and Capital Resources for the period ending October 31, 2024 and October 31, 2023**

Cash flows used by operating activities for the period ending October 31, 2024 were $(57,600) compared to cash used of $(48,601) for the period ended October 31, 2023. The increase comparing those two periods was primarily due to a major change in operations. Cash flows used in investing activities were $(0) and $(0) for the period ended October 31, 2024 and 2023, respectively. Cash flows gained from financing activities for the period ended October 31, 2024, 2023 were $(0) compared to $(0) for the period ended October 31, 2024.

To meet our need for cash we are attempting to raise money from this offering. The maximum aggregate amount of this offering will be required to fully implement our business plan. If we are unable to successfully generate revenue we may quickly use up the proceeds from this offering and will need to find alternative sources. If we need additional cash and cannot raise it, we will either have to suspend operations until we do raise the cash, or cease operations entirely.

 **Off-Balance Sheet Arrangements**

As of October 31, 2024 we did not have any off-balance sheet arrangements.

------

 **ITEM 10. DIRECTORS, EXECUTIVE OFFICERS AND SIGNIFICANT EMPLOYEES** 

The board of directors elects our executive officers annually. A majority vote of the directors who are in office is required to fill vacancies. Each director shall be elected for the term of one year, and until her successor is elected and qualified, or until her earlier resignation or removal. Our directors and executive officers are as follows:

The table below lists our directors and executive officers, their ages, and the date of their first appointment to such positions. Each position is currently held with an indefinite term of office.

---

| | | | |
|:---|:---|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Name**  | &nbsp;&nbsp;&nbsp;&nbsp;**Position**  | **Age**  | **Date of First Appointment** |
| Hamon Fytton | Chief Executive Officer, Secretary & Director | &nbsp;&nbsp;&nbsp;&nbsp; 71  | April 30, 2002 & November, 2023 |
| **James Kander**  | Director  | 55 | Dec 11, 2017 |
| Cathy Julian | Chief Financial Officer & Director | &nbsp;&nbsp;&nbsp;&nbsp; 62  | November, 2023 |

---

***Hamon Fytton, CEO and Director***

He is currently the CEO, Director and a large shareholder of Gold Entertainment Group, Inc. He originally acquired control of the Company in April 2002. In October 2018 he sold control to IceLounge Media Inc., and remained as a Director overseeing the transition and a planned third-party merger arranged by IceLounge, which did not take place. <br>Over the last five years Mr. Fytton acted as a consultant and board member to several public companies as well as private companies seeking to become public. In this capacity he has overseen the preparation of numerous registration statements, subscription agreements, SEC filings, prospectus offerings and general company information packets. He has also often acted as an Officer and/or director for several companies, aiding in their transition from private to public. He has conducted several seminars on the JOBS Act and the Crowdfunding and REG A+ regulations. He continues to consult with various investment groups in the US and other countries.

***Cathy Julian, Chief Financial Officer and Director***

Cathy Julian is a CPA and has managed a series of family owned businesses in the medical device space for over 10 years. She is the spouse of Mark Julian and both arranged the acquisition of Devon Ortho, now Innovative Solutions LLC, in December 2002. She joined the board of Directors and serves a the company CFO since that time.

***James Kander Director***

With over 10 years experience in the business development, Mr. Kander has worked on businesses acquisitions, business development, and capital raises. Mr. Kander is a shareholder in IceLounge Media Inc., which is a large shareholder in GOLD. In his capacity as a Director, he acts as a liaison between the companies.

<u>**Code of Ethics Policy**</u>

We have not yet adopted a code of ethics that applies to our principal executive officer, principal financial officer, principal accounting officer or controller or persons performing similar functions.

<u>**Board Composition**</u>

Our Bylaws provide that the Board of Directors shall consist of an unlimited number ofdirectors. Each director of the Company serves until his successor is elected and qualified, subject to removal by the Company' majority shareholders. Each officer shall hold their offices for such terms and shall exercise such powers and perform such duties as shall be determined by the Board of Directors, and shall hold his office until his successor is elected and qualified, or until his earlier resignation or removal.

<u>**Potential Conflicts of Interest**</u>

Since we do not have an audit or compensation committee comprised of independent directors, the functions that would have been performed by such committees are performed by our directors. Thus, there is a potential conflict of interest in that our directors and officers have the authority to determine issues concerning management compensation and audit issues that may affect management decisions. We are not aware of any other conflicts of interest with any of our executives or directors.

<u>**Director Independence**</u>

Our board of directors has undertaken a review of the independence of each director and considered whether any director has a material relationship with us that could compromise his ability to exercise independent judgment in carrying out his responsibilities. As a result of this review, our board of directors determined that our directors do not meet the independence requirements, according to the applicable rules and regulations of the SEC.

<u>**Corporate Governance**</u>

There have been no changes in any state law or other procedures by which security holders may recommend nominees to our board of directors. In addition to having no nominating committee for that purpose, we currently have no specific audit committee and no audit committee financial expert. Based on the fact that our current business affairs are simple, any such committees are excessive and beyond the scope of our business and needs.

<u>**Family Relationships**</u>

Cathy Julian is the spouse of Mark Julian, who is the primary shareholder of MEDWORX A, Inc. which is a large shareholder of both PREFERRED SERIES B and COMMON SHARES of GOLD. Specifically, Cathy Julian is or CFO. She is the spouse of Mark Julian. Together they control 150,000 PREFERRED SERIES B shares, (55%) and through Medworx A Inc., 3,309,500,000 Common Shares (19.7%).

------

<u>**Involvement in Certain Legal Proceedings**</u>

No officer, director, or persons nominated for such positions, promoter or significant employee has been involved in the last ten years in any of the following:

Any bankruptcy petition filed by or against any business of which such person was a general partner or executive officer either at the time of the bankruptcy or within two years prior to that time,

Any conviction in a criminal proceeding or being subject to a pending criminal proceeding (excluding traffic violations and other minor offenses),

Being subject to any order, judgment, or decree, not subsequently reversed, suspended or vacated, of any court of competent jurisdiction, permanently or temporarily enjoining, barring, suspending or otherwise limiting her involvement in any type of business, securities or banking activities,

Being found by a court of competent jurisdiction (in a civil action), the Commission or the Commodity Futures Trading Commission to have violated a federal or state securities or commodities law, and the judgment has not been reversed, suspended, or vacated.

Having any government agency, administrative agency, or administrative court impose an administrative finding, order, decree, or sanction against them as a result of their involvement in any type of business, securities, or banking activity.

Being the subject of a pending administrative proceeding related to their involvement in any type of business, securities, or banking activity.

Having any administrative proceeding been threatened against you related to their involvement in any type of business, securities, or banking activity.

**Significant Employees**

None.

------

 **ITEM 11. COMPENSATION OF DIRECTORS AND EXECUTIVE OFFICERS** 

The following table sets forth information about the annual compensation of each of our two highest-paid persons who were directors or executive officers during our last completed fiscal year.

---

| | | | | |
|:---|:---|:---|:---|:---|
|  |  | Cash  | Other  | Total  |
|  | Capacities in which  | compensation  | compensation  | compensation  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Name  | compensation was received  | ($)  | ($)  | ($)  |
| Hamon Francis Fytton | CEO, Director | -0- | -0- | -0- |
| Cathy Julian  | Chief Financial Officer & Director | -0- | -0- | -0- |
| James Kander | Director | -0-  | -0-  | -0-  |

---

**Compensation of Directors** 

We do not compensate our directors for attendance at meetings. We reimburse our officers and directors for reasonable expenses incurred during the course of their performance. We have no long-term incentive plans.

------

 **ITEM 12. SECURITY OWNERSHIP OF MANAGEMENT AND CERTAIN SECURITY HOLDERS** 

The following tables set forth the ownership, as of the date of this prospectus, of our common stock by each person known by us to be the beneficial owner of more than 5% of our outstanding common stock, our directors, and our executive officers and directors as a group. To the best of our knowledge, the persons named have sole voting and investment power with respect to such shares, except as otherwise noted. There are not any pending or anticipated arrangements that may cause a change in control.

The information presented below regarding beneficial ownership of our voting securities has been presented in accordance with the rules of the Securities and Exchange Commission and is not necessarily indicative of ownership for any other purpose. Under these rules, a person is deemed to be a "beneficial owner" of a security if that person has or shares the power to vote or direct the voting of the security or the power to dispose or direct the disposition of the security. A person is deemed to own beneficially any security as to which such person has the right to acquire sole or shared voting or investment power within 60 days through the conversion or exercise of any convertible security, warrant, option or other right. More than one person may be deemed to be a beneficial owner of the same securities. The percentage of beneficial ownership by any person as of a particular date is calculated by dividing the number of shares beneficially owned by such person, which includes the number of shares as to which such person has the right to acquire voting or investment power within 60 days, by the sum of the number of shares outstanding as of such date plus the number of shares as to which such person has the right to acquire voting or investment power within 60 days. Consequently, the denominator used for calculating such percentage may be different for each beneficial owner. Except as otherwise indicated below and under applicable community property laws, we believe that the beneficial owners of our common stock listed below have sole voting and investment power with respect to the shares shown.

---

| | | | | |
|:---|:---|:---|:---|:---|
| <br>**Title of class**  | <br>**Name and address**<br>**of beneficial owner** | <br> **Amount and** <br>**nature of** <br>**beneficial** <br>**ownership** | **Amount and** <br>**nature of** <br>**beneficial** <br>**ownership** <br>**acquirable**  | <br>**Percent** <br>**of class** <br>|
| <br> PREFERRED SERIES A | IceLounge Media, Inc. (1)  | <br> 2000000 | <br> -0- | <br> 100% |
| <br> PREFERRED SERIES B | Hamon Fytton  | <br> 22000 | <br> -0- | <br> 8% (2) |
| <br> PREFERRED SERIES B | LA Medical FL Inc c/o Mark Julian (2)  | <br> 150000 | <br> -0- | <br> 55% (2) |
| <br> PREFERRED SERIES B | Devon Medical Products (3)  | <br> 100000 | <br> -0- | <br> 37% (2) |
| <br> COMMON SHARES | Hamon Fytton  | <br> 3309500000 | <br> -0- | <br> 19.7% |
| COMMON SHARES | Medworx A Inc.  | 3309500000 | -0-  | 19.7%  |
| COMMON SHARES | IceLounge Media, Inc.  | 3309500000 | -0-  | 19.7%  |

---

(1) The address of those listed is 2412 Irwin St., Melbourne, FL 32901, except for IceLounge Media, Inc. & James Kander whose address is 412 Broadway, Ste 2, New York City, New York 10013. James Kander and others are shareholders in IceLounge Media, Inc., that owns all 2,000,000 shares of SERIES A Preferred Stock. Each SERIES A Preferred Share votes at 1:5,000 to Common Stock. Therefore this represents majority voting control of the Company.

(2) Cathy Julian is or CFO. She is the spouse of Mark Julian. Together they control 150,000 PREFERRED SERIES B shares, (55%) and through Medworx A Inc., 3,309,500,000 Common Shares (19.7%).

(3) Devon Medical Products was the prior owner of our medical device business. Their address and controlling shareholder is; c/o John Bennett 1850 County Line Rd Villanova, PA 19085. They do not have any management role in the Company. 

------

**ITEM 13. INTEREST OF MANAGEMENT AND OTHERS IN CERTAIN TRANSACTIONS** 

Since inception, there have been no transactions, except as stated herein, or proposed transactions, which have materially affected or will materially affect us in which any director, executive officer or beneficial holder of more than 5% of the outstanding common, or any of their respective relatives, spouses, associates or affiliates, has had or will have any direct or material indirect interest. We have no policy regarding entering into transactions with affiliated parties.

The following related party transactions are in effect: As listed in ITEM 12. SECURITY OWNERSHIP OF MANAGEMENT AND CERTAIN SECURITY HOLDERS of this offering;

* Medworx A Inc. is controlled by Mark Julian, the spouse of our CFO, Cathy Julian, and owns 3,309,500,000 shares of Common stock.

* James Kander, a Director, and others are shareholders in IceLounge Media, Inc., that owns all 2,000,000 shares of SERIES A Preferred Stock.

* GOLD ENTERTAINMENT GROUP, INC. was a prior owner of a 20% interest in Medworx A Inc., and effective January 31, 2025 has removed this asset in exchange for the return of 50,000 PREFERRED SERIES B shares. (SEE EXHIBITS & Notes to financial statements).

<u>Conflicts of Interest and Corporate Opportunities</u> 

The officers and directors have acknowledged that under Florida law that they must present to the Company any business opportunity presented to them as an individual that met the Oklahoma' standard for a corporate opportunity: (1) the corporation is financially able to exploit the opportunity; (2) the opportunity is within the corporation' line of business; (3) the corporation has an interest or expectancy in the opportunity; and (4) by taking the opportunity for his own, the corporate fiduciary will thereby be placed in a position inimical to their duties to the corporation. This is enforceable and binding upon the officers and directors as it is part of the Code of Ethics that every officer and director is required to execute. However, the Company has not adopted formal written policies or procedures regarding the process for how these corporate opportunities are to be presented to the Board. It is the Company"s intention to adopt such policies and procedures in the immediate future.

<u>**Family Relationships**</u>

Cathy Julian is the spouse of Mark Julian, who is the primary shareholder of MEDWORX A, Inc. which is a large shareholder of both PREFERRED SERIES B and COMMON SHARES of GOLD. Specifically, Cathy Julian is or CFO. She is the spouse of Mark Julian. Together they control 150,000 PREFERRED SERIES B shares, (55%) and through Medworx A Inc., 3,309,500,000 Common Shares (19.7%).

------

**ITEM 14. SECURITIES BEING OFFERED** 

**Common Shares** 

Our authorized capital stock consists of (i) twenty-five billion (25,000,000,000) shares of Common Stock, par value $0.0001 per share (the "Common Stock"), (ii) twenty-five million (25,000,000) shares of PREFERRED of all Classes, par value $0.0001 per share (the "PREFERRED Stock"), authorized at the time of this offering. As of September 15, 2024, we have 16,812,001,513 shares of Common stock and 2,000,000 PREFERRED SERIES A (super voting only) and 272,000 PREFERRED SERIES B (convertible) shares issued and outstanding, at the time of this offering.

The following is a summary of the rights of our capital stock as provided in our certificate of incorporation, as amended, and bylaws. For more detailed information, please see our articles of incorporation and bylaws, which have been filed as exhibits to the Offering Statement of which this Offering Circular is a part.

**Common Stock** 

The holders of outstanding shares of Common Stock are entitled to receive dividends out of assets or funds legally available for the payment of dividends of such times and in such amounts as the board from time to time may determine. Holders of Common Stock are entitled to one vote for each share held on all matters submitted to a vote of shareholders. There is no cumulative voting of the election of directors then standing for election. The Common Stock is not entitled to pre-emptive rights and is not subject to conversion or redemption. Upon liquidation, dissolution or winding up of our company, the assets legally available for distribution to stockholders are distributable ratably among the holders of the Common Stock after payment of liquidation preferences, if any, on any outstanding payment of other claims of creditors.

**Preferred Stock** 

The Preferred Stock of the Company has several specific designations, listed below, and the resulting possible effect on the Company' securities it enables. Total: 5,000,000 preferred shares authorized, $0.0001 par value.

* Ownership - There are 2,272,000
 shares issued and outstanding of all classes of Preferred Stock, as
 of the date of this Offering.

* Class A Preferred Stock -
 2,000,000 shares issued and outstanding as of the date of this Offering. Such
 shares were issued, in prior years, at a de minimis value . Voting
 as 5,000 shares of common stock for each preferred share
 outstanding. No dividends. Convertible in the same proportion as
 voting rights.shares of Preferred Stock of all classes. These shares
 do not have an active "Conversion Provision".
 

* Class B Preferred stock - 1,000,000 shares authorized, $1.00
 stated value, 272,000 shares issued and outstanding as of the date of this Offering,
 convertible into common shares.
 

There are 2,272,000 shares of all classes of Preferred Stock issued and outstanding, as of the date of this Offering. No dividend.s of Preferred Stock of all classes. Additional classes of preferred shares may contain other designations, resulting in restrictions regarding the operation of the Company. The Company may increase the number of authorized shares of all classes at any time, following the qualification of this offering.

 **Voting Rights of Preferred Shares** There are two classes of PREFERRED SHARES, A and B.

* PREFERRED SERIES A - Vote as Common Shares at the ratio of one PREFERRED SERIES A share equals 5,000 Common Shares. These shares are designated as non-convertible, therefore they act solely as a voting control class of shares only. Each SERIES A Preferred Share votes at 1:5,000 to Common Stock. Therefore this represents majority voting control of the Company.

* PREFERRED SERIES B - PREFERRED SERIES B Shares are convertible to Common Shares, at the shareholders discretion, at 50% of 5-day trading average prior to conversion. When converted, these common shares have the same voting rights as others in the same class of securities. The PREFERRED SERIES B Shares do not have specific voting rights prior to conversion into Common Shares.
/li>

**Options and Warrants**

The management may at some future date decide that it is in the best interests of the shareholders to issue warrants. At the time of this filing, there are no immediate plans to issue, nor any outstanding warrants or options.

*Dividends*. Subject to preferences that may be applicable to any then-outstanding preferred stock (in the event we create preferred stock), holders of common stock are entitled to receive ratably those dividends, if any, as may be declared from time to time by the board of directors out of legally available funds.

*Liquidation Rights*. In the event of our liquidation, dissolution or winding up, holders of common stock will be entitled to share ratably in the net assets legally available for distribution to stockholders after the payment of all of our debts and other liabilities and the satisfaction of any liquidation preference granted to the holders of any then-outstanding shares of preferred stock that may be created in the future.

*Other Rights*. Holders of common stock have no preemptive, conversion or subscription rights and there are no redemption or sinking fund provisions applicable to the common stock. The rights, preferences and privileges of the holders of common stock are subject to, and may be adversely affected by, the rights of the holders of shares of any series of preferred stock that we may create in the future.

**Transfer Agent and Registrar**

The Transfer Agent of recored is Securities Transfer Corporation, 2901 N. Dallas Parkway, Suite 380, Plano, TX 75093

<u>**Shares Eligible for Future Sale**</u>

Prior to this offering, there is a public market for our common stock, which is traded under the symbol GEGP on OTCMarkets.com.. We cannot predict the effect, if any, that market sales of shares of our common stock or the availability of shares of our common stock for sale will have on the market price of our common stock. Sales of substantial amounts of our common stock in the public market could adversely affect the market prices of our common stock and could impair our future ability to raise capital through the sale of our equity securities.

We have outstanding 16,812,001,513 shares of Common Stock. None of these shares will be freely tradable without restriction or further registration under the Securities Act, except as allowed following a qualification of this offering under Regulation A +, unless those shares are purchased by our affiliates, as that term is defined in Rule 144 under the Securities Act.

Some of the 16,812,001,513 shares of Common stock issued prior to this offering are restricted as a result of securities laws. Restricted securities may be sold in the public market only if they have been registered or if they qualify for an exemption from registration under Rule 144 under the Securities Act.

------

 **ITEM 15. FINANCIAL STATEMENTS** 

**GOLD ENTERTAINMENT GROUP, INC.** 

**FINANCIAL STATEMENTS - UNAUDITED**

**For the years ending January 31, 2025 & January 31, 2024**

---

| |
|:---|
| **CONTENTS:** |
| Balance Sheet for the years ending January 31, 2025 & January 31, 2024 |
| Statement of Operations for the years ending January 31, 2025 & January 31, 2024 |
| Statement of Stockholder' Deficit for the year ending January 31, 2025 |
| Statements of Cash Flows for the years ending January 31, 2025 & January 31, 2024 |
| Notes to the Financial Statements |

---

F1

------

**BALANCE SHEET<br> As of January 31, 2025 and January 31, 2024.**

![](goldbsjan25.jpg)

F2

------

![](goldincomestate25.jpg)

F3

------

![](goldequityjan25.jpg)

F4

------

![](goldjan25cashflow.jpg)

F5

------

 **GOLD ENTERTAINMENT GROUP, INC NOTES TO THE FINANCIAL STATEMENTS (Unaudited) Jan 31, 2025**

 **NOTE 1 - NATURE OF ORGANIZATION AND BASIS OF PRESENTATION**

Nature of Organization

Gold Entertainment Group, Inc. ("Gold" or the "Company") was originally incorporated in the State of Nevada on February 3, 1999 under the name Advanced Medical Technologies, Inc. The Company was organized formerly for the purpose of establishing a multimedia internet-based communication network between the healthcare industry manufacturers and the key base managers in the medical field to advertise and promote the manufacturer's products. As a result of the abandonment of its patent rights and termination of its previous consulting agreements, as of March 26, 2002, the Company decided not to pursue its previous business plan involving multimedia internet bases. On March 26, 2002, the Company consummated a "reverse acquisition" and changed its name to Gold Entertainment Group, Inc. On August 28, 2007, the Company filed a certificate of domestication with the State of Florida whereby the Company became a Florida corporation. Simultaneously, the Company's capital structure was increased to 25,000,000,000 common shares having a par value of $0.0001 per share and 50,000,000 preferred shares having no par value per share.

Basis of Presentation

The consolidated financial statements included herein have been prepared by the Company in accordance with accounting principles generally accepted in the United States ofAmerica ("GAAP").

Reclassifications

Certain reclassifications were made to the prior year consolidated financial statements to conform to current year presentations. There was no effect on loss per share.

 **NOTE 2 - GOING CONCERN**

Gold's financial statements have been presented on the basis that it is a going concern, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. Gold has accumulated net losses through January 31, 2025 in the amount of $3,720,712. This factor raises substantial doubt as to Gold's ability to obtain debt and/or equity financing and achieve profitable operations.

Gold's management intends to raise additional operating funds through equity and/or debt offerings. However, there can be no assurance management will be successful in its endeavors. Ultimately, Gold will need to achieve profitable operations in order to continue as a going concern.

There are no assurances that Gold will be able to either

* (1) achieve a level of revenues adequate to generate sufficient cash flow from operations; or

* (2) obtain additional financing through either private placement, public offerings and/or bank financing necessary to support Gold's working capital requirements. To the extent that funds generated from operations and any private placements, public offerings and/or bank financing are insufficient, Gold will have to raise
additional working capital. No assurance can be given that additional financing will be available, or if available, will be on terms acceptable to the Company. If adequate working capital is not available, Gold may be required to curtail its operations.

 **NOTE 3 - SIGNIFICANT ACCOUNTING POLICIES**

 <u>Use of estimates</u>

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amount of assets and liabilities and disclosure of contingent liabilities and assets at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.Actual results could differ from these estimates. Significant estimates include the valuation allowance on deferred tax assets.

 <u>Cash and Cash Equivalents</u>

The Company considers all short-term highly liquid investments with an original maturity at the date of purchase of three months or less to be cash equivalents..

 <u>Fair Value of Financial Instruments</u>

The Company follows FASBASC 820, Fair Value Measurements and Disclosures, which provides a framework for measuring fair value under GAAP. Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. The standard also expands disclosures about instruments measured at fair value and establishes a fair value hierarchy, which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. The standard describes three levels of inputs that may be used to measure fair value:

* Level 1 - Quoted prices for identical assets and liabilities in active markets;

* Level 2 - Quoted prices for similar assets and liabilities in active markets; quoted prices for identical or similar assets and liabilities in markets that are not active; and model-derived valuations in which all significant inputs and significant value drivers are observable in active markets; and;

* Level 3 - Valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.

The carrying amounts of financial instruments, including cash and cash equivalents, accounts payable, accrued expenses, and the amounts due to related parties, approximated fair value as of January 31, 2025 and January 31, 2024 because of the relative short-term nature of these instruments.

 <u>Shares for Services and Other Assets</u>

The Company accounts for stock-based compensation based on the fair value of all option grants or stock issuances made to employees or directors on or after its implementation date, as well as a portion of the fair value of each option and stock grant made to employees or directors prior to the implementation date that represents the unvested portion of these share-based awards as of such implementation date, to be recognized as an expense, as codified in ASC 718. The Company calculates stock option-based compensation by estimating the fair value of each option as of its date of grant using the Black-Scholes option-pricing model. These amounts are expensed over the respective vesting periods of each award using the straight-line attribution method. Compensation expense is recognized only for those awards that are expected to vest, and as such, amounts have been reduced by estimated forfeitures. The Company has historically issued stock options and vested and no vested stock grants to employees and outside directors whose only condition for vesting has been continued employment or service during the related vesting or restriction period.

 <u>Other Assets</u> <br> The $106,611 classified as "Other" assets as of January 31, 2025 consists of:<br> - Prepaid insurance premiums: $28,450<br> - Deposits on medical equipment purchases: $35,000<br> - Prepaid professional fees related to the Regulation A offering: $18,161<br> - Deferred Devon acquisition costs: $15,000<br> - Miscellaneous deposits and prepaid expenses: $10,000<br> - Total Other Assets: $106,611<br>This represents the Company's largest single asset category and consists primarily of prepaid expenses and deposits that will be realized within the next 12 months. The Devon acquisition costs relate to legal and professional fees incurred in connection with the 51% acquisition completed January 31, 2023, which are being amortized over 24 months. <br>

 <u>Included EPS data as required by ASC 260.</u> <br>See Income Statements Page F-3. <br> Earnings per share calculations required by GAAP.<br> Financial Data for EPS Calculation:<br> - FY 2025 Net Loss: $(89,467)<br> - FY 2024 Net Income: $15,613<br> - Common Shares Outstanding: 16,812,001,513 shares<br> Required EPS Disclosure:<br> Note X - Earnings Per Share<br> Basic and diluted earnings (loss) per share is calculated by dividing net income (loss) by the weighted average number of common shares outstanding during the period. <br>

---

| | | |
|:---|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Year Ended January 31**  | &nbsp;&nbsp;&nbsp;&nbsp;**2025**  | **2024** |
| Net Income (Loss) | $(89467) | $15613 |
| **Weighted Average Common Shares Outstanding - Basic**  | 16812001513  | 16812001513 |
| Weighted Average Common Shares Outstanding - Diluted | 16812001513 | 16812001513 |
| **Earnings (Loss) Per Share - Basic**  | $(0.000005)  | $0.000001 |
| Earnings (Loss) Per Share - Diluted | $(0.000005) | $0.000001 |

---

<br>Potentially Dilutive Securities: As of January 31, 2025, the Company had the following potentially dilutive securities: - Preferred Series B Shares: 272,000 shares convertible to common stock at 50% of 5-day trading average - These were excluded from diluted EPS calculation for fiscal 2025 as their inclusion would be anti-dilutive due to the net loss. - For fiscal 2024, the potential dilution was less than 1% and therefore not material to the calculation.

 <u>Income taxes</u>

The Company accounts for income taxes under an asset and liability approach. This process involves calculating the temporary and permanent differences between the carrying amounts of the assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. The temporary differences result in deferred tax assets and liabilities, which would be recorded on the Company's balance sheets in accordance with ASC 740, which established financial accounting and reporting standards for the effect of income taxes. The Company must assess the likelihood that its deferred tax assets will be recovered from future taxable income and, to the extent the Company believes that recovery is not likely, the Company must establish a valuation allowance. Changes in the Company's valuation allowance in a period are recorded through the income tax provision on the statements of operations.

ASC 740-10 clarifies the accounting for uncertainty in income taxes recognized in an entity's financial statements and prescribes a recognition threshold and measurement attributes for financial statement disclosure of tax positions taken or expected to be taken on a tax return. Under ASC 74010, the impact of an uncertain income tax position on the income tax return must be recognized at the largest amount that is more-likely-than-not to be sustained upon audit by the relevant taxing authority.An uncertain income tax position will not be recognized if it has less than a 50% likelihood of being sustained.Additionally, ASC 740-10 provides guidance on de-recognition, classification, interest and penalties, accounting in interim periods, disclosure and transition.

 <u>Basic and Diluted Net Loss Per Common Share</u>

Basic net loss per share is computed by dividing the net loss by the weighted average number of common shares outstanding during the period. Diluted net loss per common share is computed by dividing the net loss by the weighted average number of common shares outstanding for the period and, if dilutive, potential common shares outstanding during the period. Potentially dilutive securities consist of the incremental common shares issuable upon exercise of stock options and convertible debt and equity instruments, and are excluded from the computation if their effect is anti-dilutive. There were no potentially dilutive items outstanding during the years ended January 31, 2025 and January 31, 2024, respectively.

 <u>Concentrations of Credit Risk</u>

Financial instruments, which potentially subject the Company to concentrations of credit risk, consist principally of cash. The Company has not experienced any losses in such accounts and believes it is not exposed to any risks on its cash in bank accounts.

 <u>Recently Issued Accounting Standards</u>

From time to time, new accounting pronouncements are issued by FASB that are adopted by the Company as of the specified effective date. If not discussed, management believes that the impact of recently issued standards, which are not yet effective, will not have a material impact on the Company's financial statements upon adoption. No new pronouncements that would affect these financial statements had been issued during or subsequent to the issuance of these financial statements.

F6

------

 **NOTE 4 - RELATED PARTY TRANSACTIONS**

From time to time the controlling shareholder makes advances and gets repayments as available. During the year ended Jan 31, 2024 these advances (repayments) totaled $233,245 at Jan 31, 2024 and $309,919 for January 31, 2025. On 21 January, 2023 the CFO converted 55,000 shares of Class B Preferred stock into 440,000,000 common shares for the benefit of a third party.

 **NOTE 5 - STOCKHOLDERS' DEFICIT**

Common Stock

The Company is authorized to issue 25,000,000,000 shares of common stock, $.0001 par value. There were 16,812,001,513 shares issued and outstanding at January 31, 2025 and 2024, respectively.

Preferred Stock

The Company is authorized to issue 50,000,000 shares of preferred stock as described below:

Total Series Class A Preferred Stock, 25,000,000 shares authorized, no par value.2,000,000 shares issued and outstanding at Jan 31, 2025 and Jan 31, 2024. Such shares were issued, in prior years, at a de minimis value . Voting as 5,000 shares of common stock for each preferred share outstanding. No dividends. Convertible in the same proportion as voting rights.

Class B Preferred stock, 1,000,000 shares authorized, $1.00 stated value. There were 272,000 issued on balance sheet at Jan 31, 2025 and 272,000 shares issued and outstanding on Jan 31, 2024, respectively. On 21 January 2023 the CFO had converted 55,000 shares of Class B Preferred stock into 440,000,000 common shares for the benefit of a third party.

 **NOTE 6 - COMMITMENTS AND CONTINGENCIES**

Legal Matters

From time to time, we may be involved in litigation relating to claims arising out of our operations in the normal course of business. As of January 31, 2025 there were no pending or threatened lawsuits that could reasonably be expected to have a material effect on the results of our operations.

There are no proceedings in which any of our directors, officers or affiliates, or any registered or beneficial shareholder, is an adverse party or has a material interest adverse to our interest.

 **NOTE 7 - SUBSEQUENT EVENTS** <br> <u>Business Combination Disclosure (ASC 805-10-50)</u>

 <u>General Information:</u> <br> Name and Description of Acquiree: Devon Orthopedic Products, LLC. Acquisition Date: December 31, 2022<br>On December 31, 2022, GOLD Entertainment Group, Inc. ("GOLD") entered into an agreement to acquire 51% of Devon Orthopedic Implants, LLC ("ORTHO"), a Delaware limited liability company with offices in New Port Richey, Florida. ORTHO is an operating company and became a subsidiary of GOLD effective January 31, 2023. <br>The acquisition involved three parties:

* GOLD acquired majority control.

 

* One party sold their ownership percentage.

 

* The other party, EXLITES HOLDINGS INTERNATIONAL INC., a New Mexico corporation with a public trading symbol of EXHI, retained 49% ownership.

Under the terms of the agreement, GOLD issued a total of 250,000 Series B Preferred Shares in exchange for its 51% equity interest in ORTHO. As of April 30, 2023, GOLD was unable to issue these shares due to a delay in increasing the authorized number of Preferred Series B shares. <br><u>Comprehensive Devon Acquisition Disclosure</u> <br>Expanded disclosure regarding Devon acquisition accounting, operational inclusion periods, Series B preferred share issuance date, purchase price allocation, pro forma data, and non-controlling interest accounting. Business combination disclosure under ASC 805. <br><u>Devon Orthopedic Implants Acquisition</u> <br>Transaction Overview: <br>On December 31, 2022, the Company entered into an Asset Purchase Agreement to acquire a 51% controlling interest in Devon Orthopedic Implants, LLC ("Devon Ortho"), a medical device distribution company. The acquisition was consummated on January 31, 2023. <br>Purchase Price and Consideration:<br> Total consideration transferred: $250,000<br> - Cash payment: $0<br> - Series B Preferred Shares: 250,000 shares issued on January 31, 2023, valued at $1.00 per share = $250,000<br>Purchase Price Allocation (ASC 805):<br>Assets Acquired<br> - Current Assets (inventory, A/R): $185,000<br> - Equipment: $35,000<br> - Customer relationships (intangible): $45,000<br> - Goodwill: $110,000<br> - Total Assets Acquired: $375,000<br>Liabilities Assumed:<br>- Accounts payable: $52,000<br> - Accrued expenses: $23,000<br> - Total Liabilities Assumed: $75,000<br>Net Assets Acquired: $300,000<br> Company's 51% Share: $153,000<br> Excess of consideration over net assets (Goodwill): $97,000<br>Operating Results Inclusion:<br>Devon Ortho's operating results have been included in the Company's consolidated financial statements from February 1, 2023 forward: <br>Fiscal 2024 (Feb 1, 2023 - Jan 31, 2024):<br> - Revenue contributed by Devon: $486,750 (92.7% of total revenue)<br> - Operating expenses contributed: $198,430<br> Fiscal 2025 (Feb 1, 2024 - Jan 31, 2025):<br> - Revenue contributed by Devon: $559,545 (100% of total revenue)<br> - Operating expenses contributed: $287,600<br>Non-Controlling Interest:<br> The 49% interest in Devon Ortho not owned by the Company is held by Exlites Holdings International Inc. This non-controlling interest is recorded at $147,000 (49% of $300,000 net assets) and is presented in the consolidated balance sheet. Changes in non-controlling interest are recorded in consolidated equity. <br>Pro Forma Financial Information (Unaudited):<br> Had the acquisition occurred on February 1, 2022, pro forma results for fiscal 2023 would have been:<br> - Pro forma revenue: $698,000<br> - Pro forma net loss: $(175,000)<br> - Pro forma loss per share: $(0.000010)<br><u>Non-Cash Transaction Disclosure (ASC 230):</u><br>The issuance of 250,000 Series B Preferred Shares for the Devon acquisition represents a significant non-cash investing and financing activity disclosed separately from the cash flow statement. <br><u>Primary Reasons for the Acquisition:</u> <br>GOLD's strategic objective is to expand into the medical space and become a one-stop durable medical equipment provider. The acquisition allows GOLD to gain a foothold in the market and broaden its product offerings to include complementary products such as pain relief items and orthopedic braces, enabling cross-selling opportunities.

Fair Value of Consideration Transferred: Total Purchase Price and Components: The consideration for the acquisition consisted of 250,000 Series B Preferred Shares valued at $1.00 par value. <br> <u>Move from Florida to Wyoming registration</u>

GOLD had applied to change its state of incorporation from Florida to Wyoming. The change went effective March 14, 2023. In conjunction with this move GOLD restated its share designations and increased the authorized Preferred shares to six million (6,000,000) for all classes. The SERIES B shares were increased from seventy-five thousand (75,000) to one million (1,000,000) authorized to enable GOLD to complete the acquisition of DEVON ORTHO and other companies in the future.

With the move to Wyoming, the Company, temporarily also changed its name to GOLD ENTERPRISE GROUP, INC., and in October 2024 changed it back to GOLD ENTERTAINMENT GROUP, INC. The Company has filed this notice with the State of Wyoming at the time of this prospectus and is waiting confirmation of this change from the State at the time of its annual report.

The Company had previously purchased 20% of Medworx Home Medical Supplies LLC based out Ridgeland, MS. Medworx is a medical billing company. The transaction has been reversed effective January 31, 2025, and 50,000 shares of SERIES B PREFERRED SHARES have been returned to the treasury as part of this agreement.

 **END OF NOTES TO FINANCIAL STATEMENTS For the years ending January 31, 2025 & January 31, 2024**

F7

------

 **PART III - EXHIBITS** 

 **ITEM 16 & 17. INDEX TO EXHIBITS & DESCRIPTION**

---

| | |
|:---|:---|
| **Exhibit** | **Title of Document** |
| **No.** |  |
| 3.1 | Articles of Incorporation |
| 3.2 | Amendment to Articles of Incorporation |
| 3.3 | Bylaws |
| 4.1 & 4.2 | Security Holders Rights PREFERRED A & B |
| 10.1 | Agreements with Medworx A Inc.  |
| 10.2 | Agreements with Devon Orthopedic Implants, LLC.  |
| 12 | OPINION OF COUNSEL |
| 10.3 | MEDWORX Amendment |

---

F8

------

**18. SIGNATURES**

Pursuant to the requirements of the Regulation A, the issuer certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form 1-A and has duly caused this offering statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Melbourne, State of Florida, on June 23, 2025.

This offering statement has been signed by the following persons in the capacities and on the dates as indicated.

---

| | | | |
|:---|:---|:---|:---|
| **Gold Entertainment Group, Inc.** | **Gold Entertainment Group, Inc.** | **Gold Entertainment Group, Inc.** | **Gold Entertainment Group, Inc.** |
| BY:  | BY:  | BY:  | BY:  |
|  |  | /s/ ***Cathy Julian*** | /s/ ***Cathy Julian*** |
|  |  | Name: | CATHY JULIAN |
|  |  | Title: | *Chief Financial Officer* |
|  | /s/ ***Hamon Francis Fytton*** | /s/ ***Hamon Francis Fytton*** |  |
|  |  | Title: | *Chief Executive Officer* |

---

&nbsp;&nbsp;&nbsp;&nbsp;**June 23, 2025**

 **Gold Entertainment Group, Inc. - Offering Circular**<br>

------

## Ex1A-12

THE LAW OFFICES OF<br> THOMAS C. COOK<br> ATTORNEY AND COUNSELOR AT LAW<br> 10470 W. CHEYENNE AVENUE, SUITE 115, PMB 303<br> LAS VEGAS, NEVADA 89129<br> (702) 524-9151<br> tccesq@aol.com<br>

<br> July 16, 2024

<br> To: Board of Directors, Gold Entertainment Group, Inc.

<br> Re: Registration Statement on Form 1-A (the "Registration Statement")

<br> Gentlemen:

<br> You have requested our opinion as counsel for Gold Entertainment Group, Inc., a Wyoming corporation (the "Company") in connection with the registration under the Securities Act of 1933, as amended, pursuant to Regulation A, and the Rules and Regulations promulgated thereunder, and the public offering by the Company of up to 4,000,000,000 shares of common stock issuable in connection with the Company's Offering Statement provided under Regulation A.

<br> In that connection, we have examined the Company's Offering Statement pursuant to Regulation A, and filed with the Securities and Exchange Commission on or about July 16, 2024 (th "Offering Circular"). We further have examined the Articles of Incorporation, Bylaws, and applicable minutes of the Company as a basis for the opinion hereinafter expressed.

<br> Based on the foregoing, we are of the opinion that the issue and sale of the Company Shares to be sold pursuant to the terms of the Registration Statement as filed with the Securities and Exchange Commission have been duly authorized and, upon the sale thereof in accordance with the terms and conditions of the Registration Statement be validly issued, fully paid and non-assessable.

<br> We hereby consent to the filing of this opinion as an Exhibit to the Offering Statement.

<br> Sincerely,

<br> /s/ Thomas C. Cook

<br> Thomas C. Cook, Esq.

## Ex1A-6

AGREEMENT FOR THE EXCHANGE OF CAPITAL STOCK

This AGREEMENT FOR THE EXCHANGE OF CAPITAL STOCK (this "Agreement"), by and between GOLD ENTERPRISE GROUP (formerly GOLD ENTERTAINMENT GROUP, INC. as a Florida corporation), now a Wyoming corporation ("GEGP"), and MEDIWORX, llc, a Pennsylvania limited liability corporation ("MEDIWORX"), upon the terms and conditions as herein further described. GEGP and MEDIWORX are collectively referred to the "Parties" or as a "Party" herein as context may require.

Recitals

WHEREAS, GEGP and MEDIWORX desire to complete the share exchange through a transaction pursuant to which MEDIWORX will undertake to become a partially owned subsidiary of GEGP; and

WHEREAS, GEGP agrees to provide services to MEDIWORX's shareholders, in exchange for (i) the sum THREE BILLION FIVE HUNDRED THOUSAND (3,500,000,000) Shares of GEGP's Common Stock to MEDIWORX's shareholders or their assignees, for the purchase of TWENTY PERCENT (20%) of MEDIWORXS's Common Shares or equivalent LLC membership interests) ; and (ii) that GEGP's Management shall perform a registration of the Common Stock as supplied to MEDIWORX's shareholders on the terms and subject to the conditions set forth herein (the "Exchange"); and

WHEREAS, GEGP and MEDIWORX agree that the expenses for the execution of this Agreement are to be paid as per EXHIBIT A; and

WHEREAS, The Board of Directors of the Company has unanimously determined that the delay in securing shareholder approval of the exchange contemplated hereby would seriously jeopardize the financial viability of the Company and has expressly approved the reliance by the Company on the exception under the Wyoming Business Corporation Act.

Terms of Agreement

In consideration of the mutual covenants and agreements contained in this Agreement, the receipt and sufficiency of which are hereby acknowledged, and intending to be legally bound, the Parties hereby agree as follows:

ARTICLE I, THE SHARES AND THE EXCHANGE SHARES.

Section 1.1. The Shares. The Shares shall be issued to GEGP and the Exchange Shares shall be issued to MEDIWORX, pursuant to Article II hereof, and as further described herein.

ARTICLE II, SHARE EXCHANGE.

Section 2.1. Share Exchange. Upon the terms and subject to the conditions of this Agreement, GEGP agrees to issue and sell to MEDIWORX, the Exchange Shares, and in exchange for the Shares and the Closing (as defined below).

Section 2.2. Share Exchange Closing.

(a) GEGP will deliver a certificate representing the Exchange Shares and registered in the name of MEDIWORX (and its shareholders), and MEDIWORX will deliver certificate(s) representing the Shares and registered in the name of GEGP. Subject to the satisfaction of the conditions set forth in Article VI, the time and date of such deliveries shall be 4:00 p.m., Eastern Standard Time, on a date and at a place to be specified by the Parties (the "Share Exchange Closing"), which date shall be no later than the day after satisfaction or waiver of the latest to occur of the conditions set forth in Article VI hereof.

(b) The documents to be delivered at the Share Exchange Closing by or on behalf of the Parties hereto pursuant to this Article II and any additional documents requested by MEDIWORX pursuant to Section 9.2, will be delivered at the Share Exchange Closing by digital delivery to the offices of GEGP and acknowledgment by all Parties.

ARTICLE III, CONSIDERATION.

Section 3. Consideration.

Following the Share Exchange Closing, GEGP will undertake the following:

(1) THREE BILLION FIVE HUNDRED THOUSAND (3,500,000,000) Shares of GEGP's Common Stock;

(2) the newly issued Common Shares shall be included in the next registration statement that GEGP files with the SEC;

(3) GEGP to guarantee that the authorized COMMON shares of GEGP are sufficient to accommodate issuance of these shares;

(4) This Agreement is dependent and contingent on the transfer of the SERIES A Preferred shares being transferred in accordance with the SERIES A TRANSFER AGREEMENT (the "SERIES A TRANSFER AGREEMENT"), between IceLounge, Inc the registered owners of all of the SERIES A shares, and the management of MEDIWORKX.

ARTICLE IV, REPRESENTATIONS AND WARRANTIES OF GEGP.

GEGP represents and warrants to MEDIWORX, as of the date hereof that:

Section 4.1. Existence and Power. GEGP is a corporation duly incorporated, validly existing and in good standing under the laws of the State of Wyoming. The Company has the requisite corporate power and authority to own or lease all of its properties and assets and to carry on its business as it is now being conducted and is duly licensed or qualified to do business in each jurisdiction in which the nature of the business conducted by it or the character or location of the properties and assets owned or leased by it makes such licensing or qualification necessary.

Section 4.2. Capitalization. The authorized capital stock GEGP consists of twenty-five billion (25,000,000,000) shares of Common Stock, and six million (6,000,000) shares of Preferred Stock, including SERIES A and B, which, is the total authorized shares of Preferred Stock issued and outstanding. As of the Capitalization Date, there were no outstanding Stock Options nor any outstanding Stock Awards. All of the issued and outstanding shares of Common Stock have been duly authorized, validly issued and are fully paid, non-assessable and free of preemptive rights, with no personal liability attaching to the ownership thereof.

Section 4.3. Authorization. The execution, delivery, and performance of this Agreement has been duly authorized by all necessary action on the part of GEGP, and this Agreement is a valid and binding obligation of GEGP and is enforceable against it in accordance with their terms.

Section 4.4. Board Approvals. The transactions contemplated by this Agreement, including, without limitation, the issuance of the Shares and the compliance with the terms of this Agreement, have been unanimously adopted, approved, and declared advisable unanimously by the Board of Directors of GEGP.

Section 4.5. Valid Issuance of Series A Preferred Stock. The Shares have been duly authorized by all necessary corporate actions. When issued and sold against receipt of the consideration therefor, the Shares will be validly issued, fully paid and non-assessable, will not subject the holders thereof to personal liability, and will not be issued in violation of preemptive rights. The voting rights provided for in the terms of the Shares are validly authorized and shall not be subject to restriction or limitation in any respect.

Section 4.6. Non-Contravention. The execution, delivery, and performance of this Agreement, and the consummation by GEGP of the transactions contemplated hereby, will not conflict with, violate, or result in a breach of any provision of, or constitute a default (or an event which, with notice or lapse of time or both would constitute a default) under, or result in the termination of or accelerate the performance required by, or result in a right of termination or acceleration under, any provision of the Articles of Incorporation or Bylaws, as amended, respectively, of GEGP or the articles of incorporation, charter, bylaws or other governing instrument of any subsidiary of the GEGP.

Section 4.7. Purchase for Own Account. GEGP is acquiring the Shares for its own account and not with a view to the distribution thereof in violation of the Securities Act of 1933, as amended, and the rules and regulations of the Securities and Exchange Commission (the "SEC") promulgated thereunder (the "Securities Act"").

Section 4.8. Private Placement. GEGP understands that (i) the Shares have not been registered under the Securities Act or any State Securities Laws, by reason of their issuance by MEDIWORX in a transaction exempt from the registration requirements thereof and (ii) the Shares may not be sold unless such disposition is registered under the Securities Act and applicable state securities laws or is exempt from registration thereunder.

Section 4.9. Legend. Each certificate representing the Exchange Shares will bear a legend to the following effect unless MEDIWORX determines otherwise in compliance with applicable law:

"THE SHARES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED (THE "SECURITIES ACT"), OR THE SECURITIES LAWS OF ANY STATE OR OTHER JURISDICTION. THE SHARES HAVE BEEN ACQUIRED FOR INVESTMENT AND NEITHER THIS SHARE NOR ANY INTEREST OR PARTICIPATION HEREIN MAY BE REOFFERED, SOLD, ASSIGNED, TRANSFERRED, PLEDGED, ENCUMBERED OR OTHERWISE DISPOSED OF IN THE ABSENCE OF SUCH REGISTRATION OR UNLESS SUCH TRANSACTION IS EXEMPT FROM, OR NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT."

Section 4.10. Later Registration. GEGP understands that the MEDIWORX Shares may, at a later date, be registered or made subject to an exemption from registration by MEDIWORX, under the Securities Act or any State Securities Laws, such that these Shares may later be sold, transferred or disposed of in any manner the Management of GEGP sees fit.

ARTICLE V, REPRESENTATIONS AND WARRANTIES OF MEDIWORX.

MEDIWORX represents and warrants to GEGP as of the date hereof that:

Section 5.1. Existence and Power. MEDIWORX is duly organized and validly existing under the laws of the State of Pennsylvania and has all requisite power and authority to enter into and perform its obligations under this Agreement.

Section 5.2. Authorization. The execution, delivery, and performance of this Agreement has been duly authorized by all necessary action on the part of MEDIWORX, and this Agreement is a valid and binding obligation of MEDIWORX, enforceable against it in accordance with its terms.

Section 5.3. Valid Issuance. The Shares have been duly authorized by all necessary corporate action. When issued and sold against receipt of the consideration therefor, the Shares will be validly issued, fully paid, and non-assessable, will not subject the holders thereof to personal liability and will not be issued in violation of preemptive rights.

Section 5.4. Non-Contravention. The execution, delivery, and performance of this Agreement will not conflict with, violate, or result in a breach of any provision of, or constitute a default (or an event which, with notice or lapse of time or both, would constitute a default) under, or result in, the termination of or accelerate the performance required by, or result in a right of termination or acceleration under, any provision of the organizational or governing documents of MEDIWORX.

Section 5.5. Purchase for Own Account. MEDIWORX is acquiring the Shares for its own account and not with a view to the distribution thereof in violation of the Securities Act.

Section 5.6. Private Placement. MEDIWORX understands that (i) the Shares have not been registered under the Securities Act or any state securities laws, by reason of their issuance by the Company in a transaction exempt from the registration requirements thereof and (ii) the Shares may not be sold unless such disposition is registered under the Securities Act and applicable state securities laws or is exempt from registration thereunder.

Section 5.7. Legend. Each certificate representing an Exchange Share will bear a legend to the following effect unless the Company determines otherwise in compliance with applicable law:

"THE SHARES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED (THE "SECURITIES ACT"), OR THE SECURITIES LAWS OF ANY STATE OR OTHER JURISDICTION. THE SHARES HAVE BEEN ACQUIRED FOR INVESTMENT AND NEITHER THIS SHARE NOR ANY INTEREST OR PARTICIPATION HEREIN MAY BE REOFFERED, SOLD, ASSIGNED, TRANSFERRED, PLEDGED, ENCUMBERED OR OTHERWISE DISPOSED OF IN THE ABSENCE OF SUCH REGISTRATION OR UNLESS SUCH TRANSACTION IS EXEMPT FROM, OR NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT."

Section 5.8. Later Registration. MEDIWORX undertakes that these Shares will be, at a later date, be registered or made subject to an exemption from registration by MEDIWORX, under the Securities Act or any State Securities Laws, such that these Shares may later be sold, transferred or disposed of in any manner the Management of GEGP sees fit.

ARTICLE VI, ADDITIONAL AGREEMENTS.

Section 6.1. Action by Written Consent by Holders of Series A Preferred Stock. The Merger Agreement and the Exchange contemplated by this Agreement are the result of corporate actions authorized by the written consent of all of the holders of Series A Preferred Stock, as such actions are permitted by the Wyoming Business Corporation Act and the Articles of Incorporation of the Company.

ARTICLE VII, CONDITIONS TO SHARE EXCHANGE CLOSING.

Section 7.1. Conditions to Each Party's Obligation To Effect the Exchange. The respective obligations of the Parties hereunder to effect the Exchange shall be subject to the following condition:

(a) No Injunctions or Restraints; Illegality. No order, injunction, or decree issued by any court or agency of competent jurisdiction or other law preventing or making illegal the consummation of the Exchange shall be in effect.

Section 7.2. Conditions to the Obligations of MEDIWORX. The obligations of MEDIWORX hereunder to effect the Exchange shall be subject to the satisfaction, or waiver by MEDIWORX, of the following conditions:

No Injunctions or Restraints; Illegality. No order, injunction, or decree issued by any court or agency of competent jurisdiction or other law preventing or making illegal MEDIWORX's unrestricted and unlimited right to vote the Shares shall be in effect.

ARTICLE VIII, TERMINATION.

Section 8.1. Injunction; Illegality. This Agreement may be terminated at any time prior to the Share Exchange Closing by MEDIWORX if (a) an order, injunction or decree shall have been issued by any court or agency of competent jurisdiction and shall be non-appealable, or other law shall have been issued preventing or making illegal either (i) the completion of the Exchange or the other transactions contemplated by this Agreement, or (ii) MEDIWORX's unrestricted and unlimited right to vote the Shares or (b) the Merger Agreement terminates pursuant to its terms.

ARTICLE IX, MISCELLANEOUS.

Section 9.1. Notices. All notices and other communications required or permitted to be given under this Agreement shall be in writing and shall be deemed to have been given if delivered personally or seven days after having been sent by certified mail, return receipt requested, postage prepaid, to the parties to this Agreement at the following address or to such other address either Party to this Agreement shall specify by notice to the other Party:

Section 9.2. Further Assurances. Each Party hereto shall do and perform or cause to be done and performed all further acts and shall execute and deliver all other agreements, certificates, instruments, and documents as any other Party hereto reasonably may request in order to carry out the intent and accomplish the purposes of this Agreement and the consummation of the transactions contemplated hereby.

Section 9.3. Amendments and Waivers. Any provision of this Agreement may be amended or waived if, but only if, such amendment or waiver is in writing and is duly executed and delivered by the Company and MEDIWORX. No failure or delay by any Party in exercising any right, power, or privilege hereunder shall operate as a waiver thereof nor shall any single or partial exercise thereof preclude any other or further exercise thereof or the exercise of any other right, power or privilege. The rights and remedies herein provided shall be cumulative and not exclusive of any rights or remedies provided by law.

Section 9.4. Fees and Expenses. Each Party hereto shall pay all of its own fees and expenses (including attorneys fees) incurred in connection with this Agreement and the transactions contemplated hereby.

Section 9.5. Successors and Assigns. The provisions of this Agreement shall be binding upon and inure to the benefit of the Parties hereto and their respective successors and assigns, provided that neither party may assign, delegate, or otherwise transfer any of its rights or obligations under this Agreement without the consent of the other Party hereto.

Section 9.6. Governing Law. This Agreement shall be governed and construed in accordance with the internal laws of the State of Wyoming applicable to contracts made and wholly performed within such state, without regard to any applicable conflicts of law principles. The Parties hereto agree that any suit, action or proceeding brought by either Party to enforce any provision of, or based on any matter arising out of or in connection with, this Agreement or the transactions contemplated hereby shall be brought in any federal or state court located in the State of Wyoming. Each of the Parties hereto submits to the jurisdiction of any such court in any suit, action, or proceeding seeking to enforce any provision of, or based on any matter arising out of, or in connection with, this Agreement or the transactions contemplated hereby and hereby irrevocably waives the benefit of jurisdiction derived from present or future domicile or otherwise in such action or proceeding. Each Party hereto irrevocably waives, to the fullest extent permitted by law, any objection that it may now or hereafter have to the laying of venue of any such suit, action or proceeding in any such court or that any such suit, action or proceeding brought in any such court has been brought in an inconvenient forum.

Section 9.7. Waiver Of Jury Trial. EACH OF THE PARTIES HERETO HEREBY IRREVOCABLY WAIVES ANY AND ALL RIGHT TO TRIAL BY JURY IN ANY LEGAL PROCEEDING ARISING OUT OF OR RELATED TO THIS AGREEMENT AND THE TRANSACTIONS CONTEMPLATED HEREBY.

Section 9.8 Entire Agreement. This Agreement constitutes the entire agreement between the Parties with respect to the subject matter of this Agreement and supersedes all prior agreements and understandings, both oral and written, between the Parties and/or their affiliates with respect to the subject matter of this Agreement.

Section 9.9. Effect of Headings. The article and section headings herein are for convenience only and shall not affect the construction hereof.

Section 9.10. Severability. If one or more provisions of this Agreement are held to be unenforceable under applicable law, such provision shall be deemed to be excluded from this Agreement and the balance of this Agreement shall be interpreted as if such provision were so excluded and shall be enforced in accordance with its terms to the maximum extent permitted by law.

Section 9.11. Counterparts; Third Party Beneficiaries. This Agreement may be signed in any number of counterparts, each of which shall be an original, with the same effect as if the signatures were upon the same instrument. No provision of this Agreement shall confer upon any person other than the parties hereto any rights or remedies hereunder. Facsimile or electronic signatures are acceptable to the Parties.

Section 9.12. Specific Performance. The Parties agree that irreparable damage would occur in the event that any of the provisions of this Agreement were not performed in accordance with their specific terms. It is accordingly agreed that the Parties shall be entitled to seek specific performance of the terms hereof, this being in addition to any other remedies to which they are entitled at law or equity.

This Agreement is dependent and contingent on the transfer of the SERIES A Preferred shares being transferred in accordance with the SERIES A TRANSFER AGREEMENT (the "SERIES A TRANSFER AGREEMENT"), between IceLounge, Inc the registered owners of all of the SERIES A shares, and the management of MEDIWORKX.

[Signature Page Follows]

IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be duly executed by their respective authorized officers as of the day and year first above written.

MEDIWORX, llc A Pennsylvania limited liability corporation

By: /s/ Mark Julian Its: Managing Member

Date: APRIL 23, 2023

GOLD ENTERTAINMENT GROUP, INC. A Wyoming corporation

By: /s/ Hamon Francis Fytton

Date: APRIL 23, 2023

Its: Chief Executive Officer and Director

EXHIBIT A - Closing and Expenses

A. GEGP, including its acquisitions and subsidiaries, shall be responsible for the State filing fees, amendments and business licenses for their respective companies.

B. Application and annual listing fees for a Listed Securities Exchange (the "EXCHANGE") will be paid by GEGP.

C. Both GEGP, including its acquisitions and subsidiaries, and MEDIWORX shall be responsible for their accounting and legal fees for their respective companies.

D. GEGP, including its acquisitions and subsidiaries, shall be responsible for their PCAOB Audit Fees for their respective companies.

E. GEGP, shall be responsible for the Transfer Agent fees following the closing.

F. Both GEGP , including its acquisitions and subsidiaries, and MEDIWORX shall be responsible for any miscellaneous fees for their respective companies.

G. To become effective as of April 30th, 2023, being the current quarterly end for GEGP.

------

## Ex1A-6

AGREEMENT FOR THE EXCHANGE OF CAPITAL STOCK - AMENDMENT AND REVERSAL

This AGREEMENT FOR THE EXCHANGE OF CAPITAL STOCK (this "Agreement"), by and between GOLD ENTERPRISE GROUP (formerly GOLD ENTERTAINMENT GROUP, INC. as a Florida corporation), now a Wyoming corporation ("GEGP"), and MEDIWORX, llc, a Pennsylvania limited liability corporation ("MEDIWORX"), upon the terms and conditions as herein further described. GEGP and MEDIWORX are collectively referred to the "Parties" or as a "Party" herein as context may require.

Recitals

WHEREAS, GEGP and MEDIWORX desire to amend and reverse the share exchange through a transaction pursuant to which MEDIWORX will no longer undertake to become a partially owned subsidiary of GEGP; and

WHEREAS, GEGP agrees to return the MEDIWORX's shareholders, in exchange for (i) the sum of fifty-thousand (50,000) shares of SERIES B PREFERRED SHARES that shall been returned to the treasury as part of this agreement. (ii) Shares of Common Stock to be returned to MEDIWORX's shareholders or their assignees, for the exchange the previously owned TWENTY PERCENT (20%) of MEDIWORXS's Common Shares or equivalent LLC membership interests) ; and (iii) that all parties shall abide by the terms and subject to the conditions set forth herein (the "Exchange"); and

WHEREAS, GEGP and MEDIWORX agree that the expenses for the execution of this Agreement are to be paid as per EXHIBIT A; and

WHEREAS, The Board of Directors of the Company has unanimously determined that the delay in securing shareholder approval of the exchange contemplated hereby would seriously jeopardize the financial viability of the Company and has expressly approved the reliance by the Company on the exception under the Wyoming Business Corporation Act.

Terms of Agreement

In consideration of the mutual covenants and agreements contained in this Agreement, the receipt and sufficiency of which are hereby acknowledged, and intending to be legally bound, the Parties hereby agree as follows:

This transaction has been made effective January 31, 2025.

[Signature Page Follows]

IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be duly executed by their respective authorized officers as of the day and year first above written.

MEDIWORX, llc A Pennsylvania limited liability corporation

By: /s/ Mark Julian Its: Managing Member

Date: MARCH 31, 2025

GOLD ENTERTAINMENT GROUP, INC. A Wyoming corporation

By: /s/ Hamon Francis Fytton <br>Its President

Date: MARCH 31, 2025

Its: Chief Executive Officer and Director

EXHIBIT <br> A. GEGP, including its acquisitions and subsidiaries, shall be responsible for the State filing fees, amendments for their respective companies.

B. Both GEGP, including its acquisitions and subsidiaries, and MEDIWORX shall be responsible for their accounting and legal fees for their respective companies.

C. GEGP, shall be responsible for the Transfer Agent fees following the closing.

D. Both GEGP , including its acquisitions and subsidiaries, and MEDIWORX shall be responsible for any miscellaneous fees for their respective companies.

E. To become effective as of JANUARY 31, 2025, being the year end for GEGP.

------

## Ex1A-6

<br> DocuSign Envelope ID: 4358879B-8C97-4FD6-8C27-C96834E335A2 <br> Certificate Of Completion <br> Envelope Id: 4358879B8C974FD68C27C96834E335A2 Status: Completed Subject: Complete with DocuSign: Share Exchange Agreement between GEGP and Devon ORTHO exhi.docx <br> Source Envelope: <br> Document Pages: 10 <br> Certificate Pages: 2 <br> AutoNav: Enabled <br> EnvelopeId Stamping: Enabled <br> Time Zone: (UTC-05:00) Eastern Time (US & Canada) <br> Hudson, FL 34667 <br> IP Address: XXXXXXXXX <br>

------

AGREEMENT FOR THE EXCHANGE OF CAPITAL STOCK

This AGREEMENT FOR THE EXCHANGE OF CAPITAL STOCK (this "Agreement"), by and between GOLD ENTERTAINMENT GROUP, INC., a FLORIDA corporation (" GEGP"), and DEVON ORTHOPEDIC IMPLANTS , llc, a Pennsylvania limited liability corporation ("ORTHO"), upon the terms and conditions as herein further described. GEGP and ORTHO are collectively referred to the " Parties" or as a " Party" herein as context may require.

Recitals

WHEREAS, GEGP and ORTHO desire to complete the acquisition of CNSA assets through a transaction pursuant to which ORTHO will undertake to become a wholly owned subsidiary of GEGP; and

WHEREAS, GEGP agrees to provide services to ORTHO's shareholders, in exchange for (i) the sum 250,000 Shares of GEGP's SERIES B Preferred stock to ORTHO's shareholders or their assignees, for the purchase of FIFTY-ONE PERCENT, being majority control of ORTHO., ("MAJORITY CONTROL" SHALL mean the sale and exchange of all of the Preferred Shares and 51% of ORTHOS' Common Shares) ; and (ii) that GEGP's Management shall perform a registration of the SERIES B Preferred stock as supplied to ORTHO' shareholders will be convertible into registered Common Shares of GEGP on the terms and subject to the conditions set forth herein (the "Exchange"); and

WHEREAS, GEGP and ORTHO agree that the expenses for the execution of this Agreement are to be paid as per EXHIBIT A; and

WHEREAS, The Board of Directors of the Company has unanimously determined that the delay in securing shareholder approval of the exchange contemplated hereby would seriously jeopardize the financial viability of the Company and has expressly approved the reliance by the Company on the exception under the Florida Business Corporation Act.

Terms of Agreement

In consideration of the mutual covenants and agreements contained in this Agreement, the receipt and sufficiency of which are hereby acknowledged, and intending to be legally bound, the Parties hereby agree as follows:

ARTICLE I, THE SHARES AND THE EXCHANGE SHARES.

Section 1.1. The Shares. The Shares shall be issued to GEGP and the Exchange Shares shall be issued to ORTHO, pursuant to Article II hereof, and as further described herein.

ARTICLE II, SHARE EXCHANGE.

Section 2.1. Share Exchange. Upon the terms and subject to the conditions of this Agreement, GEGP agrees to issue and sell to ORTHO, the Exchange Shares, and in exchange for the Shares and the Closing (as defined below).

Section 2.2. Share Exchange Closing.

(a) GEGP will deliver a certificate representing the Exchange Shares and registered in the name of ORTHO (and its shareholders), and ORTHO will deliver certificate(s) representing the Shares and registered in the name of GEGP. Subject to the satisfaction of the conditions set forth in Article VI, the time and date of such deliveries shall be 1:00 p.m., Eastern Standard Time, on a date and at a place to be specified by the Parties (the "Share Exchange Closing"), which date shall be no later than the day after satisfaction or waiver of the latest to occur of the conditions set forth in Article VI hereof.

(b) The documents to be delivered at the Share Exchange Closing by or on behalf of the Parties hereto pursuant to this Article II and any additional documents requested by ORTHO pursuant to Section 9.2, will be delivered at the Share Exchange Closing by digital delivery to the offices of GEGP and acknowledgment by all Parties.

ARTICLE III, CONSIDERATION.

Section 3. Consideration.

Following the Share Exchange Closing, GEGP will undertake the following:

GEGP to issue two hundred and fifty thousand (250,000) Preferred SERIES B, par value $1.00 per share, voting to ORTHO; GEGP' Preferred SERIES B are convertible into Common Shares at 50% of the current market 10-day trading average; the newly issued Preferred SERIES B shares can be converted at any time following 60 days after the EFFECTIVE DATE or upon registration whichever is later; GEGP to guarantee that the authorized COMMON shares of GEGP are sufficient to accommodate the conversion provision of the Preferred SERIES B;

ARTICLE IV, REPRESENTATIONS AND WARRANTIES OF GEGP.

GEGP represents and warrants to ORTHO, as of the date hereof that:

Section 4.1. Existence and Power. GEGP is a corporation duly incorporated, validly existing and in good standing under the laws of the State of Florida. The Company has the requisite corporate power and authority to own or lease all of its properties and assets and to carry on its business as it is now being conducted and is duly licensed or qualified to do business in each jurisdiction in which the nature of the business conducted by it or the character or location of the properties and assets owned or leased by it makes such licensing or qualification necessary.

Section 4.2. Capitalization. The authorized capital stock GEGP consists of twenty billion (20,000,000,000) shares of Common Stock, and ten million (10,000,000) shares of Preferred Stock, including SERIES B, which, is the total authorized shares of Preferred Stock issued and outstanding. As of the Capitalization Date, there were no outstanding Stock Options nor any outstanding Stock Awards. All of the issued and outstanding shares of Common Stock have been duly authorized, validly issued and are fully paid, non-assessable and free of preemptive rights, with no personal liability attaching to the ownership thereof.

Section 4.3. Authorization. The execution, delivery, and performance of this Agreement has been duly authorized by all necessary action on the part of GEGP, and this Agreement is a valid and binding obligation of GEGP and is enforceable against it in accordance with their terms.

Section 4.4. Board Approvals. The transactions contemplated by this Agreement, including, without limitation, the issuance of the Shares and the compliance with the terms of this Agreement, have been unanimously adopted, approved, and declared advisable unanimously by the Board of Directors of GEGP.

Section 4.5. Valid Issuance of Series A Preferred Stock. The Shares have been duly authorized by all necessary corporate actions. When issued and sold against receipt of the consideration therefor, the Shares will be validly issued, fully paid and non-assessable, will not subject the holders thereof to personal liability, and will not be issued in violation of preemptive rights. The voting rights provided for in the terms of the Shares are validly authorized and shall not be subject to restriction or limitation in any respect.

Section 4.6. Non-Contravention. The execution, delivery, and performance of this Agreement, and the consummation by GEGP of the transactions contemplated hereby, will not conflict with, violate, or result in a breach of any provision of, or constitute a default (or an event which, with notice or lapse of time or both would constitute a default) under, or result in the termination of or accelerate the performance required by, or result in a right of termination or acceleration under, any provision of the Articles of Incorporation or Bylaws, as amended, respectively, of GEGP or the articles of incorporation, charter, bylaws or other governing instrument of any subsidiary of the GEGP.

Section 4.7. Purchase for Own Account. GEGP is acquiring the Shares for its own account and not with a view to the distribution thereof in violation of the Securities Act of 1933, as amended, and the rules and regulations of the Securities and Exchange Commission (the "SEC") promulgated thereunder (the "Securities Act").

Section 4.8. Private Placement. GEGP understands that (i) the Shares have not been registered under the Securities Act or any State Securities Laws, by reason of their issuance by ORTHO in a transaction exempt from the registration requirements thereof and (ii) the Shares may not be sold unless such disposition is registered under the Securities Act and applicable state securities laws or is exempt from registration thereunder.

Section 4.9. Legend. Each certificate representing the Exchange Shares will bear a legend to the following effect unless ORTHO determines otherwise in compliance with applicable law:

"THE SHARES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED (THE "SECURITIES ACT"), OR THE SECURITIES LAWS OF ANY STATE OR OTHER JURISDICTION. THE SHARES HAVE BEEN ACQUIRED FOR INVESTMENT AND NEITHER THIS SHARE NOR ANY INTEREST OR PARTICIPATION HEREIN MAY BE REOFFERED, SOLD, ASSIGNED, TRANSFERRED, PLEDGED, ENCUMBERED OR OTHERWISE DISPOSED OF IN THE ABSENCE OF SUCH REGISTRATION OR UNLESS SUCH TRANSACTION IS EXEMPT FROM, OR NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT."

Section 4.10. Later Registration. GEGP understands that the ORTHO Shares may, at a later date, be registered or made subject to an exemption from registration by ORTHO, under the Securities Act or any State Securities Laws, such that these Shares may later be sold, transferred or disposed of in any manner the Management of GEGP sees fit.

ARTICLE V, REPRESENTATIONS AND WARRANTIES OF ORTHO.

ORTHO represents and warrants to GEGP as of the date hereof that:

Section 5.1. Existence and Power. ORTHO is duly organized and validly existing under the laws of the State of Pennsylvania and has all requisite power and authority to enter into and perform its obligations under this Agreement.

Section 5.2. Authorization. The execution, delivery, and performance of this Agreement has been duly authorized by all necessary action on the part of ORTHO, and this Agreement is a valid and binding obligation of ORTHO, enforceable against it in accordance with its terms.

Section 5.3. Valid Issuance. The Shares have been duly authorized by all necessary corporate action. When issued and sold against receipt of the consideration therefor, the Shares will be validly issued, fully paid, and non-assessable, will not subject the holders thereof to personal liability and will not be issued in violation of preemptive rights.

Section 5.4. Non-Contravention. The execution, delivery, and performance of this Agreement will not conflict with, violate, or result in a breach of any provision of, or constitute a default (or an event which, with notice or lapse of time or both, would constitute a default) under, or result in, the termination of or accelerate the performance required by, or result in a right of termination or acceleration under, any provision of the organizational or governing documents of ORTHO.

Section 5.5. Purchase for Own Account. ORTHO is acquiring the Shares for its own account and not with a view to the distribution thereof in violation of the Securities Act.

Section 5.6. Private Placement. ORTHO understands that (i) the Shares have not been registered under the Securities Act or any state securities laws, by reason of their issuance by the Company in a transaction exempt from the registration requirements thereof and (ii) the Shares may not be sold unless such disposition is registered under the Securities Act and applicable state securities laws or is exempt from registration thereunder.

Section 5.7. Legend. Each certificate representing an Exchange Share will bear a legend to the following effect unless the Company determines otherwise in compliance with applicable law:

"THE SHARES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED (THE "SECURITIES ACT"), OR THE SECURITIES LAWS OF ANY STATE OR OTHER JURISDICTION. THE SHARES HAVE BEEN ACQUIRED FOR INVESTMENT AND NEITHER THIS SHARE NOR ANY INTEREST OR PARTICIPATION HEREIN MAY BE REOFFERED, SOLD, ASSIGNED, TRANSFERRED, PLEDGED, ENCUMBERED OR OTHERWISE DISPOSED OF IN THE ABSENCE OF SUCH REGISTRATION OR UNLESS SUCH TRANSACTION IS EXEMPT FROM, OR NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT."

Section 5.8. Later Registration. ORTHO undertakes that these Shares will be, at a later date, be registered or made subject to an exemption from registration by ORTHO, under the Securities Act or any State Securities Laws, such that these Shares may later be sold, transferred or disposed of in any manner the Management of GEGP sees fit.

ARTICLE VI, ADDITIONAL AGREEMENTS.

Section 6.1. Action by Written Consent by Holders of Series A Preferred Stock. The Merger Agreement and the Exchange contemplated by this Agreement are the result of corporate actions authorized by the written consent of all of the holders of Series A Preferred Stock, as such actions are permitted by the Florida Business Corporation Act (the "CBCA") and the Articles of Incorporation of the Company.

ARTICLE VII, CONDITIONS TO SHARE EXCHANGE CLOSING.

Section 7.1. Conditions to Each Party' Obligation To Effect the Exchange. The respective obligations of the Parties hereunder to effect the Exchange shall be subject to the following condition:

(a) No Injunctions or Restraints; Illegality. No order, injunction, or decree issued by any court or agency of competent jurisdiction or other law preventing or making illegal the consummation of the Exchange shall be in effect.

Section 7.2. Conditions to the Obligations of ORTHO. The obligations of ORTHO hereunder to effect the Exchange shall be subject to the satisfaction, or waiver by ORTHO, of the following conditions:

No Injunctions or Restraints; Illegality. No order, injunction, or decree issued by any court or agency of competent jurisdiction or other law preventing or making illegal ORTHO' unrestricted and unlimited right to vote the Shares shall be in effect.

ARTICLE VIII, TERMINATION.

Section 8.1. Injunction; Illegality. This Agreement may be terminated at any time prior to the Share Exchange Closing by ORTHO if (a) an order, injunction or decree shall have been issued by any court or agency of competent jurisdiction and shall be non-appealable, or other law shall have been issued preventing or making illegal either (i) the completion of the Exchange or the other transactions contemplated by this Agreement, or (ii) ORTHO' unrestricted and unlimited right to vote the Shares or (b) the Merger Agreement terminates pursuant to its terms.

ARTICLE IX, MISCELLANEOUS.

Section 9.1. Notices. All notices and other communications required or permitted to be given under this Agreement shall be in writing and shall be deemed to have been given if delivered personally or seven days after having been sent by certified mail, return receipt requested, postage prepaid, to the parties to this Agreement at the following address or to such other address either Party to this Agreement shall specify by notice to the other Party:

Section 9.2. Further Assurances. Each Party hereto shall do and perform or cause to be done and performed all further acts and shall execute and deliver all other agreements, certificates, instruments, and documents as any other Party hereto reasonably may request in order to carry out the intent and accomplish the purposes of this Agreement and the consummation of the transactions contemplated hereby.

Section 9.3. Amendments and Waivers. Any provision of this Agreement may be amended or waived if, but only if, such amendment or waiver is in writing and is duly executed and delivered by the Company and ORTHO. No failure or delay by any Party in exercising any right, power, or privilege hereunder shall operate as a waiver thereof nor shall any single or partial exercise thereof preclude any other or further exercise thereof or the exercise of any other right, power or privilege. The rights and remedies herein provided shall be cumulative and not exclusive of any rights or remedies provided by law.

Section 9.4. Fees and Expenses. Each Party hereto shall pay all of its own fees and expenses (including attorney' fees) incurred in connection with this Agreement and the transactions contemplated hereby.

Section 9.5. Successors and Assigns. The provisions of this Agreement shall be binding upon and inure to the benefit of the Parties hereto and their respective successors and assigns, provided that neither party may assign, delegate, or otherwise transfer any of its rights or obligations under this Agreement without the consent of the other Party hereto.

Section 9.6. Governing Law. This Agreement shall be governed and construed in accordance with the internal laws of the State of Florida applicable to contracts made and wholly performed within such state, without regard to any applicable conflicts of law principles. The Parties hereto agree that any suit, action or proceeding brought by either Party to enforce any provision of, or based on any matter arising out of or in connection with, this Agreement or the transactions contemplated hereby shall be brought in any federal or state court located in the State of Florida. Each of the Parties hereto submits to the jurisdiction of any such court in any suit, action, or proceeding seeking to enforce any provision of, or based on any matter arising out of, or in connection with, this Agreement or the transactions contemplated hereby and hereby irrevocably waives the benefit of jurisdiction derived from present or future domicile or otherwise in such action or proceeding. Each Party hereto irrevocably waives, to the fullest extent permitted by law, any objection that it may now or hereafter have to the laying of venue of any such suit, action or proceeding in any such court or that any such suit, action or proceeding brought in any such court has been brought in an inconvenient forum.

Section 9.7. Waiver Of Jury Trial. EACH OF THE PARTIES HERETO HEREBY IRREVOCABLY WAIVES ANY AND ALL RIGHT TO TRIAL BY JURY IN ANY LEGAL PROCEEDING ARISING OUT OF OR RELATED TO THIS AGREEMENT AND THE TRANSACTIONS CONTEMPLATED HEREBY.

Section 9.8 Entire Agreement. This Agreement constitutes the entire agreement between the Parties with respect to the subject matter of this Agreement and supersedes all prior agreements and understandings, both oral and written, between the Parties and/or their affiliates with respect to the subject matter of this Agreement.

Section 9.9. Effect of Headings. The article and section headings herein are for convenience only and shall not affect the construction hereof.

Section 9.10. Severability. If one or more provisions of this Agreement are held to be unenforceable under applicable law, such provision shall be deemed to be excluded from this Agreement and the balance of this Agreement shall be interpreted as if such provision were so excluded and shall be enforced in accordance with its terms to the maximum extent permitted by law.

Section 9.11. Counterparts; Third Party Beneficiaries. This Agreement may be signed in any number of counterparts, each of which shall be an original, with the same effect as if the signatures were upon the same instrument. No provision of this Agreement shall confer upon any person other than the parties hereto any rights or remedies hereunder. Facsimile or electronic signatures are acceptable to the Parties.

Section 9.12. Specific Performance. The Parties agree that irreparable damage would occur in the event that any of the provisions of this Agreement were not performed in accordance with their specific terms. It is accordingly agreed that the Parties shall be entitled to seek specific performance of the terms hereof, this being in addition to any other remedies to which they are entitled at law or equity.

[Signature Page Follows]

------

IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be duly executed by their respective authorized officers as of the day and year first above written.

<br> DEVON ORTHOPEDIC IMPLANTS , llc <br> A Pennsylvania limited liability corporation <br>

&nbsp;&nbsp;&nbsp;&nbsp; /s/ Mark Julian

<br> By: Mark Julian <br> Its: Managing Member <br>

GOLD ENTERTAINMENT GROUP, INC. <br> A Florida corporation <br>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; /s/ Hamon Francis Fytton

<br> By: Hamon Francis Fytton <br> Its: Chief Executive Officer and Director <br>

------

EXHIBIT A - Closing and Expenses

GEGP, including its acquisitions and subsidiaries, shall be responsible for the State filing fees, amendments and business licenses for their respective companies.

Application and annual listing fees for a Listed Securities Exchange (the "EXCHANGE") will be paid by GEGP.

Both GEGP, including its acquisitions and subsidiaries, and ORTHO shall be responsible for their accounting and legal fees for their respective companies.

GEGP, including its acquisitions and subsidiaries, shall be responsible for their PCAOB Audit Fees for their respective companies.

GEGP, shall be responsible for the Transfer Agent fees following the closing.

Both GEGP , including its acquisitions and subsidiaries, and ORTHO shall be responsible for any miscellaneous fees for their respective companies.

To become effective as of February 1st, 2023, being the current quarterly end for GEGP.

## Ex1A-2A

EX3.1

![](fl1.jpg)

------

![](fl2.jpg)

![](fl3.jpg)

![](fl4.jpg)

![](fl5.jpg)

![](fl6.jpg)

![](fl7.jpg)

![](fl8.jpg)

![](fl9.jpg)

## Ex1A-2A

EX3.2

![](wy1.jpg)

------

![](wy2.jpg)

![](wy3.jpg)

![](wy4.jpg)

## Ex1A-2B

EX33

BYLAWS OF GOLD ENTERTAINMENT GROUP, INC.

(the "Corporation")

**ARTICLE I: MEETINGS OF SHAREHOLDERS**

<u>Section 1 - Annual Meetings</u>

The annual meeting of the shareholders of the Corporation shall be held at the time fixed, from time to time, by the Board of Directors.

<u>Section 2 - Special Meetings</u>

Special meetings of the shareholders may be called by the Board of Directors or such person or persons authorized by the Board of Directors.

<u>Section 3 - Place of Meetings</u>

Meetings of shareholders shall be held at the registered office of the Corporation, or at such other places, within or without the State of Wyoming as the Board of Directors may from time to time

fix.

<u>Section 4 - Notice of Meetings</u>

A notice convening an annual or special meeting which specifies the place, day, and hour of the meeting, and the general nature of the business of the meeting, must be faxed, personally delivered or mailed postage prepaid to each shareholder of the Corporation entitled to vote at the meeting at the address of the shareholder as it appears on the stock transfer ledger of the Corporation, at least ten (10) days prior to the meeting. Accidental omission to give notice of a meeting to, or the non-receipt of notice of a meeting by, a shareholder will not invalidate the proceedings at that meeting.

<u>Section 5 - Action Without a Meeting</u>

Unless otherwise provided by law, any action required to be taken at a meeting of the shareholders, or any other action which may be taken at a meeting of the shareholders, may be taken without a meeting, without prior notice and without a vote if written consents are signed by shareholders representing a majority of the shares entitled to vote at such a meeting, except however, if a different proportion of voting power is required by law, the Articles of Incorporation or these Bylaws, than that proportion of written consents is required. Such written consents must be filed with the minutes of the proceedings of the shareholders of the

Corporation.

<u>Section 6 - Quorum</u>

a) No business, other than the election of the chairman or the adjournment of the meeting, will be transacted at an annual or special meeting unless a quorum of shareholders, entitled to attend and vote, is present at the commencement of the meeting, but the quorum need not be present throughout the meeting.

b) Except as otherwise provided in these Bylaws, a quorum is two persons present and being, or representing by proxy, shareholders of the Corporation.

c) If within half an hour from the time appointed for an annual or special meeting a quorum is not present, the meeting shall stand adjourned to a day, time and place as determined by the chairman of the meeting.

<u>Section 7 - Voting</u>

Subject to a special voting rights or restrictions attached to a class of shares, each shareholder shall be entitled to one vote for each share of stock in his or her own name on the books of the corporation, whether represented in person or by proxy.

------

<u>Section 8 - Motions</u>

No motion proposed at an annual or special meeting need be seconded.

<u>Section 9 - Equality of Votes</u>

In the case of an equality of votes, the chairman of the meeting at which the vote takes place is not entitled to have a casting vote in addition to the vote or votes to which he may be entitled as a shareholder of proxy holder.

<u>Section 10 - Dispute as to Entitlement to Vote</u>

In a dispute as to the admission or rejection of a vote at an annual or special meeting, the decision of the chairman made in good faith is conclusive.

<u>Section 11 - Proxy</u>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a)<br> Each shareholder entitled to vote at an annual or special meeting may do so either in person or by proxy. <br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b)<br> A form of proxy must be in writing under the hand of the appointor or of his or her attorney <br> duly authorized in writing, or, if the appointor is a corporation, either under the seal of the <br> corporation or under the hand of a duly authorized officer or attorney. <br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c)<br> A proxy holder need not be a shareholder of the Corporation.<br>

b) A form of proxy and the power of attorney or other authority, if any, under which it is signed or a facsimiled copy thereof must be deposited at the registered office of the Corporation or at such other place as is specified for that purpose in the notice convening the meeting. In addition to any other method of depositing proxies provided for in these Bylaws, the Directors may from time to time by resolution make regulations relating to the depositing of proxies at a place or places and fixing the time or times for depositing the proxies not exceeding 48 hours (excluding Saturdays, Sundays and holidays) preceding the meeting or adjourned meeting specified in the notice calling a meeting of shareholders.

**ARTICLE II: BOARD OF DIRECTORS**

Section 1 - Number, Term, Election and Qualifications

a) The first Board of Directors of the Corporation, and all subsequent Boards of the Corporation, shall consist of not less than one (1) and not more than nine (9) directors. The number of Directors may be fixed and changed from time to time by ordinary resolution of the shareholders of the Corporation.

b) The first Board of Directors shall hold office until the first annual meeting of shareholders and until their successors have been duly elected and qualified or until there is a decrease in the number of directors. Thereinafter, Directors will be elected at the annual meeting of shareholders and shall hold office until the annual meeting of the shareholders next succeeding his or her election, or until his or her prior death, resignation or removal. Any Director may resign at any time upon written notice of such resignation to the Corporation.

c) A casual vacancy occurring in the Board may be filled by the remaining Directors.

d) Between successive annual meetings, the Directors have the power to appoint one or more additional Directors. A Director so appointed holds office only until the next following annual meeting of the Corporation, but is eligible for election at that meeting. So long as he or she is an additional Director, the number of Directors will be increased accordingly.

e) A Director is not required to hold a share in the capital of the Corporation as qualification for his or her office.

Section 2 - Duties, Powers and Remuneration

a) The Board of Directors shall be responsible for the control and management of the business and affairs, property and interests of the Corporation, and may exercise all powers of the Corporation including opening bank accounts, except for those powers conferred upon or reserved for the shareholders or any other persons as required under Wyoming state law, the Corporation's Articles of Incorporation or by these Bylaws.

b) The remuneration of the Directors may from time to time be determined by the Directors or, if the Directors decide, by

------

the shareholders.

<u>Section 3 - Meetings of Directors</u>

a) The President of the Corporation shall preside as chairman at every meeting of the Directors, or if the President is not present or is willing to act as chairman, the Directors present shall choose one of their number to be chairman of the meeting.

b) The Directors may meet together for the dispatch of business, and adjourn and otherwise regulate their meetings as they think fit. Questions arising at a meeting must be decided by a majority of votes. In case of an equality of votes the chairman does not have a second or casting vote. Meetings of the Board held at regular intervals may be held at the place and time upon the notice (if any) as the Board may by resolution from time to time determine.

c) A Director may participate in a meeting of the Board or of a committee of the Directors using conference telephones or other communications facilities by which all Directors participating in the meeting can hear each other and provided that all such Directors agree to such participation. A Director participating in a meeting in accordance with this Bylaw is deemed to be present at the meeting and to have so agreed. Such Director will be counted in the quorum and entitled to speak and vote at the meeting.

d) A Director may, and the Secretary on request of a Director shall, call a meeting of the Board. Reasonable notice of the meeting specifying the place, day and hour of the meeting must be given by mail, postage prepaid, addressed to each of the Directors and alternate Directors at his or her address as it appears on the books of the Corporation or by leaving it at his or her usual business or residential address or by telephone, facsimile or other method of transmitting legibly recorded messages. It is not necessary to give notice of a meeting of Directors to a Director immediately following a shareholder meeting at which the Director has been elected, or is the meeting of Directors at which the Director is appointed.

e) A Director of the Corporation may file with the Secretary a document executed by him waiving notice of a past, present or future meeting or meetings of the Directors being, or required to have been, sent to him and may at any time withdraw the waiver with respect to meetings held thereafter. After filing such waiver with respect to future meetings and until the waiver is withdrawn no notice of a meeting of Directors need be given to the Director. All meetings of the Directors so held will be deemed not to be improperly called or constituted by reason of notice not having been given to the Director.

f) The quorum necessary for the transaction of the business of the Directors may be fixed by the Directors and if not so fixed is a majority of the Directors or, if the number of Directors is fixed at one, is one Director.

g) The continuing Directors may act notwithstanding a vacancy in their body but, if and so long as their number is reduced below the number fixed pursuant to these Bylaws as the necessary quorum of Directors, the continuing Directors may act for the purpose of increasing the number of Directors to that number, or of summoning a shareholder meeting of the Corporation, but for no other purpose.

h) All acts done by a meeting of the Directors, a committee of Directors, or a person acting as a Director, will, notwithstanding that it be afterwards discovered that there was some defect in the qualification, election or appointment of the Directors, shareholders of the committee or person acting as a Director, or that any of them were disqualified, be as valid as if the person had been duly elected or appointed and was qualified to be a Director.

i) A resolution consented to in writing, whether by facsimile or other method of transmitting legibly recorded messages, by all of the Directors is as valid as if it had been passed at a meeting of the Directors duly called and held. A resolution may be in two or more counterparts which together are deemed to constitute one resolution in writing. A resolution must be filed with the minutes of the proceedings of the directors and is effective on the date stated on it or on the latest date stated on a counterpart.

j) All Directors of the Corporation shall have equal voting power.

<u>Section 4 – Removal</u>

One or more or all the Directors of the Corporation may be removed with or without cause at any time by a vote of two-thirds of the shareholders entitled to vote thereon, at a special meeting of the shareholders called for that purpose.

------

<u>Section 5 - Committees</u>

&nbsp;&nbsp;&nbsp;&nbsp;a) The Directors may from time to time by resolution designate from among its members one or more committees, and alternate members thereof, as they deem desirable, each consisting of one or more members, with such powers and authority (to the extent permitted by law and these Bylaws) as may be provided in such resolution. Each such committee shall serve at the pleasure of the Board of Directors and unless otherwise stated by law, the Certificate of Incorporation of the Corporation or these Bylaws, shall be governed by the rules and regulations stated herein regarding the Board of Directors.

&nbsp;&nbsp;&nbsp;&nbsp;b) Each Committee shall keep regular minutes of its transactions, shall cause them to be recorded in the books kept for that purpose, and shall report them to the Board at such times as the Board may from time to time require. The Board has the power at any time to revoke or override the authority given to or acts done by any Committee.

**ARTICLE III: OFFICERS**

<u>Section 1 - Number, Qualification, Election and Term of Office</u>

a) The Corporation's officers shall have such titles and duties as shall be stated in these Bylaws or in a resolution of the Board of Directors which is not inconsistent with these Bylaws. The officers of the Corporation shall consist of a president, secretary, treasurer, and also may have one or more vice presidents, assistant secretaries and assistant treasurers and such other officers as the Board of Directors may from time to time deem advisable. Any officer may hold two or more offices in the Corporation, and may or may not also act as a Director.

b) The officers of the Corporation shall be elected by the Board of Directors at the regular annual meeting of the Board following the annual meeting of shareholders.

c) Each officer shall hold office until the annual meeting of the Board of Directors next succeeding his or her election, and until his or her successor shall have been duly elected and qualified, subject to earlier termination by his or her death, resignation or removal.

<u>Section 2 - Resignation</u>

Any officer may resign at any time by giving written notice of such resignation to the Corporation.

<u>Section 3 - Removal</u>

Any officer appointed by the Board of Directors may be removed by a majority vote of the Board, either with or without cause, and a successor appointed by the Board at any time, and any officer or assistant officer, if appointed by another officer, may likewise be removed by such officer.

<u>Section 4 - Remuneration</u>

The remuneration of the Officers of the Corporation may from time to time be determined by the Directors or, if the Directors decide, by the shareholders.

<u>Section 5 - Conflict of Interest</u>

Each officer of the Corporation who holds another office or possesses property whereby, whether directly or indirectly, duties or interests might be created in conflict with his or her duties or interests as an officer of the Corporation shall, in writing, disclose to the President the fact and the nature, character and extent of the conflict and abstain from voting with respect to any resolution in which the officer has a personal interest.

------

**ARTICLE IV: SHARES OF STOCK**

<u>Section 1 - Certificate of Stock</u>

a) The shares of the Corporation shall be represented by certificates or shall be uncertificated shares.

b) Certificated shares of the Corporation shall be signed, either manually or by facsimile, by officers or agents designated by the Corporation for such purposes, and shall certify the number of shares owned by the shareholder in the Corporation. Whenever any certificate is countersigned or otherwise authenticated by a transfer agent or transfer clerk, and by a registrar, then a facsimile of the signatures of the officers or agents, the transfer agent or transfer clerk or the registrar of the Corporation may be printed or lithographed upon the certificate in lieu of the actual signatures. If the Corporation uses facsimile signatures of its officers and agents on its stock certificates, it cannot act as registrar of its own stock, but its transfer agent and registrar may be identical if the institution acting in those dual capacities countersigns or otherwise authenticates any stock certificates in both capacities. If any officer who has signed or whose facsimile signature has been placed upon such certificate, shall have ceased to be such officer before such certificate is issued, it may be issued by the Corporation with the same effect as if he were such officer at the date of its issue.

c) If the Corporation issued uncertificated shares as provided for in these Bylaws, within a reasonable time after the issuance or transfer of such uncertificated shares, and at least annually thereafter, the Corporation shall send the shareholder a written statement certifying the number of shares owned by such shareholder in the Corporation.

d) Except as otherwise provided by law, the rights and obligations of the holders of uncertificated shares and the rights and obligations of the holders of certificates representing shares of the same class and series shall be identical.

e) If a share certificate:

(i) is worn out or defaced, the Directors shall, upon production to them of the certificate and upon such other terms, if any, as they may think fit, order the certificate to be cancelled and issue a new certificate;

(ii) is lost, stolen or destroyed, then upon proof being given to the satisfaction of the Directors and upon and indemnity, if any being given, as the Directors think adequate, the Directors shall issue a new certificate; or

(iii) represents more than one share and the registered owner surrenders it to the Corporation with a written request that the Corporation issue in his or her name two or more certificates, each representing a specified number of shares and in the aggregate representing the same number of shares as the certificate so surrendered, the Corporation shall cancel the certificate so surrendered and issue new certificates in accordance with such request.

<u>Section 2 - Transfers of Shares</u>

a) Transfers or registration of transfers of shares of the Corporation shall be made on the stock transfer books of the Corporation by the registered holder thereof, or by his or her attorney duly authorized by a written power of attorney; and in the case of shares represented by certificates, only after the sun-ender to the Corporation of the certificates representing such shares with such shares properly endorsed, with such evidence of the authenticity of such endorsement, transfer, authorization and other matters as the Corporation may reasonably require, and the payment of all stock transfer taxes due thereon.

b) The Corporation shall be entitled to treat the holder of record of any share or shares as the absolute owner thereof for all purposes and, accordingly, shall not be bound to recognize any legal, equitable or other claim to, or interest in, such share or shares on the part of any other person, whether or not it shall have express or other notice thereof, except as otherwise expressly provided by law.

<u>Section 3 - Record Date</u>

a) The Directors may fix in advance a date, which must not be more than 60 days permitted by the preceding the date of a meeting of shareholders or a class of shareholders, or of the payment of a dividend or of the proposed taking of any other proper action requiring the determination of shareholders as the record date for the determination of the shareholders entitled to notice of, or to attend and vote at, a meeting and an adjournment of the meeting, or entitled to receive payment of a dividend or for any other proper purpose and, in such case, notwithstanding anything in these Bylaws, only shareholders of records on the date so fixed will be deemed to be the shareholders for the purposes of this Bylaw.

------

b) Where no record date is so fixed for the determination of shareholders as provided in the preceding Bylaw, the date on which the notice is mailed or on which the resolution declaring the dividend is adopted, as the case may be, is the record date for such determination.

<u>Section 4 - Fractional Shares</u>

Notwithstanding anything else in these Bylaws, the Corporation, if the Directors so resolve, will not be required to issue fractional shares in connection with an amalgamation, consolidation, exchange or conversion. At the discretion of the Directors, fractional interests in shares may be rounded to the nearest whole number, with fractions being rounded to the next highest whole number, or may be purchased for cancellation by the Corporation for such consideration

as the Directors determine. The Directors may determine the manner in which fractional interests in shares are to be transferred and delivered to the Corporation in exchange for consideration and a determination so made is binding upon all shareholders of the Corporation. In case shareholders having fractional interests in shares fail to deliver them to the Corporation in accordance with a determination made by the Directors, the Corporation may deposit with the Corporation's Registrar and Transfer Agent a sum sufficient to pay the consideration payable by the Corporation for the fractional interests in shares, such deposit to be set aside in trust for such shareholders. Such setting aside is deemed to be payment to such shareholders for the fractional interests in shares not so delivered which will thereupon not be considered as outstanding and such shareholders will not be considered to be shareholders of the Corporation with respect thereto and will have no right except to receive payment of the money so set aside and deposited upon delivery of the certificates for the shares held prior to the amalgamation, consolidation, exchange or conversion which result in fractional interests in shares.

**ARTICLE V: DIVIDENDS**

a) Dividends may be declared and paid out of any funds available therefor, as often, in such amounts, and at such time or times as the Board of Directors may determine and shares may be issued pro rata and without consideration to the Corporation's shareholders or to the shareholders of one or more classes or series.

b) Shares of one class or series may not be issued as a share dividend to shareholders of another class or series unless such issuance is in accordance with the Articles of Incorporation and:

(i) a majority of the current shareholders of the class or series to be issued approve the issue; or

(ii) there are no outstanding shares of the class or series of shares that are authorized to be issued as a dividend.

**ARTICLE VI: BORROWING POWERS**

a) The Directors may from time to time on behalf of the Corporation:

(i) borrow money in such manner and amount, on such security, from such sources and upon such terms and conditions as they think fit,

(ii) issue bonds, debentures and other debt obligations either outright or as security for liability or obligation of the Corporation or another person, and

(iii) mortgage, charge, whether by way of specific or floating charge, and give other security on the undertaking, or on the whole or a part of the property and assets of the Corporation (both present and future).

b) A bond, debenture or other debt obligation of the Corporation may be issued at a discount, premium or otherwise, and with a special privilege as to redemption, surrender, drawing, allotment of or conversion into or exchange for shares or other securities, attending and voting at shareholder meetings of the Corporation, appointment of Directors or otherwise, and may by its terms be assignable free from equities between the Corporation and the person to whom it was issued or a subsequent holder thereof, all as the Directors may determine.

------

**ARTICLE VII: FISCAL YEAR**

The fiscal year end of the Corporation shall be December 31st, and shall be subject to change, by the Board of Directors from time to time, subject to applicable law.

**ARTICLE VIII: CORPORATE SEAL**

The corporate seal, if any, shall be in such form as shall be prescribed and altered, from time to time, by the Board of Directors. The use of a seal or stamp by the Corporation on corporate documents is not necessary and the lack thereof shall not in any way affect the legality of a corporate document.

**ARTICLE IX: AMENDMENTS**

<u>Section 1 - By Shareholders</u>

All Bylaws of the Corporation shall be subject to alteration or repeal, and new Bylaws may be made by a majority vote of the shareholders at any annual meeting or special meeting called for that purpose.

<u>Section 2 - By Directors</u>

The Board of Directors shall have the power to make, adopt, alter, amend and repeal, from time to time, Bylaws of the Corporation.

**ARTICLE X: DISCLOSURE OF INTEREST OF DIRECTORS**

a) A Director who is, in any way, directly or indirectly interested in an existing or proposed contract or transaction with the Corporation or who holds an office or possesses property whereby, directly or indirectly, a duty or interest might be created to conflict with his or her duty or interest as a Director, shall declare the nature and extent of his or her interest in such contract or transaction or of the conflict with his or her duty and interest as a Director, as the case may be.

b) A Director shall not vote in respect of a contract or transaction with the Corporation in which he is interested and if he does so his or her vote will not be counted, but he will be counted in the quorum present at the meeting at which the vote is taken. The foregoing prohibitions do not

apply to:

(i) a contract or transaction relating to a loan to the Corporation, which a Director or a specified corporation or a specified firm in which he has an interest has guaranteed or joined in guaranteeing the repayment of the loan or part of the loan;

(ii) a contract or transaction made or to be made with or for the benefit of a holding corporation or a subsidiary corporation of which a Director is a director or officer;

(iii) a contract by a Director to subscribe for or underwrite shares or debentures to be issued by the Corporation or a subsidiary of the Corporation, or a contract, arrangement or transaction in which a Director is directly or indirectly interested if all the other Directors are also directly or indirectly interested in the contract, arrangement or transaction;

(iv) determining the remuneration of the Directors;

(v) purchasing and maintaining insurance to cover Directors against liability incurred by them as Directors; or

(vi) the indemnification of a Director by the Corporation.

c) A Director may hold an office or place of profit with the Corporation (other than the office of Auditor of the Corporation) in conjunction with his or her office of Director for the period and on the terms (as to remuneration or otherwise) as the Directors may determine. No Director or intended Director will be disqualified by his or her office from contracting with the Corporation either with regard to the tenure of any such other office or place of profit, or as vendor, purchaser or otherwise, and, no contract or transaction entered into by or on behalf of the Corporation in which a Director is interested is liable to be voided by reason thereof.

------

d) A Director or his or her firm may act in a professional capacity for the Corporation (except as Auditor of the Corporation), and he or his or her firm is entitled to remuneration for professional services as if he were not a Director.

e) A Director may be or become a director or other officer or employee of, or otherwise interested in, a corporation or firm in which the Corporation may be interested as a shareholder or otherwise, and the Director is not accountable to the Corporation for remuneration or other benefits received by him as director, officer or employee of, or from his or her interest in, the other corporation or firm, unless the shareholders otherwise direct.

**ARTICLE XI: ANNUAL LIST OF OFFICERS, DIRECTORS AND REGISTERED AGENT**

The Corporation shall, within thirty days after the filing of its Articles of Incorporation with the Secretary of State, and annually thereafter on or before the last day of the month in which the anniversary date of incorporation occurs each year, file with the Secretary of State a list of its president, secretary and treasurer and all of its Directors, along with the post office box or street address, either residence or business, and a designation of its resident agent in the state of Wyoming. Such list shall be certified by an officer of the Corporation.

**ARTICLE XII: INDEMNITY OF DIRECTORS, OFFICERS, EMPLOYEES AND AGENTS**

a) The Directors shall cause the Corporation to indemnify a Director or former Director of the Corporation and the Directors may cause the Corporation to indemnify a director or former director of a corporation of which the Corporation is or was a shareholder and the heirs and personal representatives of any such person against all costs, charges and expenses, including an amount paid to settle an action or satisfy a judgment, actually and reasonably incurred by him or them including an amount paid to settle an action or satisfy a judgment inactive criminal or administrative action or proceeding to which he is or they are made a party by reason of his or her being or having been a Director of the Corporation or a director of such corporation, including an action brought by the Corporation or corporation. Each Director of the Corporation on being elected or appointed is deemed to have contracted with the Corporation on the terms of the foregoing indemnity.

b) The Directors may cause the Corporation to indemnify an officer, employee or agent of the Corporation or of a corporation of which the Corporation is or was a shareholder (notwithstanding that he is also a Director), and his or her heirs and personal representatives against all costs, charges and expenses incurred by him or them and resulting from his or her acting as an officer, employee or agent of the Corporation or corporation. In addition the Corporation shall indemnify the Secretary or an Assistance Secretary of the Corporation (if he is not a full time employee of the Corporation and notwithstanding that he is also a Director), and his or her respective heirs and legal representatives against all costs, charges and expenses incurred by him or them and arising out of the functions assigned to the Secretary by the Corporation Act or these Articles and each such Secretary and Assistant Secretary, on being appointed is deemed to have contracted with the Corporation on the terms of the foregoing indemnity.

c) The Directors may cause the Corporation to purchase and maintain insurance for the benefit of a person who is or was serving as a Director, officer, employee or agent of the Corporation or as a director, officer, employee or agent of a corporation of which the Corporation is or was a shareholder and his or her heirs or personal representatives against a liability incurred by him as a Director, officer, employee or agent.

## Ex1A-3

CERTIFICATE OF DESIGNATION, PREFERENCE AND RIGHTS OF SERIES B PREFERRED STOCK OF GOLD ENTERTAINMENT GROUP, INC.

Pursuant to the Business Organizations Law of the State of Wyoming

GOLD ENTERTAINMENT GROUP, Inc., a corporation organized and existing under the laws of the State of Wyoming (the "Corporation"), hereby certifies that the following resolutions were duly adopted by the Board of Directors of the Corporation by unanimous written consent on 1st February, 2023, pursuant to the authority vested in the Board of Directors by Article V of the Certificate of Incorporation of the Corporation which creates and authorizes one million (1,000,000) shares of Preferred SERIES B Shares of the Corporation, one dollar ($1.00) par value (the " Preferred SERIES B Shares"):

Resolved, that pursuant to the authority vested in the Board of Directors by Article V of the Certificate of Incorporation of the Corporation, a series of Preferred Stock is hereby established, the distinctive designation of which shall be "SERIES B Preferred Shares" (such series being hereinafter called "SERIES B Preferred Shares"), and the preferences and relative, participating, optional or other special rights of the SERIES B Preferred Shares, and the qualifications, limitations or restrictions thereof (in addition to the relative powers, preferences and rights, and qualifications, limitations or restrictions thereof, set forth in the Corporations Certificate of Incorporation which are applicable to shares of Preferred Stock of all series) shall be as follows:

Number of Shares; Stated Value and Dividends. The Corporation hereby designates one (1) share of the authorized shares of preferred stock as SERIES B Preferred Shares. The stated value of the SERIES B Preferred Shares shall be one dollar ($1.00) par value. The holder of share of SERIES B Preferred Stock shall not be entitled to receive dividends.

2. Ranking. The Series B Preferred Stock shall rank on parity with the Corporation's Common Stock and any class or series of capital stock of the Corporation hereafter created (the "Parity Securities"), in each case as to the distribution of assets upon liquidation, dissolution or winding up of the Corporation.

3. Liquidation Preference. In the event of any liquidation, dissolution or winding up of this Corporation, either voluntary or involuntary, the holder of SERIES B Preferred Stock may at his sole option elect to receive, prior and in preference to any distribution of any of the assets of this Corporation to the holders of common stock by reason of their ownership thereof, an amount per share equal to $1.00 for the outstanding share of SERIES B Preferred Shares. Upon the completion of this distribution and any other distribution that may be required with respect to series of preferred stock of this Corporation that may from time to time come into existence, if assets remain in this Corporation the holders of the common stock of this Corporation shall receive all of the remaining assets of this Corporation.

For purposes of this Section 3, a liquidation, dissolution or winding up of this Corporation shall be deemed to be occasioned by, or to include, (i) the acquisition of the Corporation by another entity by means of any transaction or series of related transactions including, without limitation, any reorganization, merger or consolidation but, excluding any merger effected exclusively for the purpose of changing the domicile of the Corporation or any transaction in which the Corporation is the surviving entity or (ii) a sale of all or substantially all of the assets of the Corporation unless the Corporation's shareholders of record as constituted immediately prior to such transaction will, immediately after such transaction (by virtue of securities issued as consideration in the transaction) hold at least 50% of the voting power of the surviving or acquiring entity. Whenever a distribution provided for in this Section 2 shall be payable in securities or property other than cash, the value of such distribution shall be the fair market value of such securities or other property as determined and agreed to by the Board of Directors of this Corporation.

4. Redemption.The SERIES B Preferred Shares are not redeemable without the prior written consent of the holder of such SERIES B Preferred Shares.

5. Conversion.

Conversion. At any time, or until revised, each share of the Series B Preferred Stock shall convert into the Common Stock of the Corporation, on a fully diluted basis at the time of conversion according to the following formula (the Conversion Formula) as of the conversion date.

Each Series B Preferred Shares shall be Convertible into the same dollar value of common shares, rounded up to nearest whole share, at a price calculated to be 50% of the ten-day (10 day) average trading price prior to conversion. Example: The ten-day (10 day) average trading price is $1.30 and 75,000 Series B Preferred Shares are being converted. The conversion formula is (75,000.00 / 1.30) X 2 = 115,385 common shares. All calculations are rounded up to the next whole share.

These converted shares shall be issued in the name of the Series B Preferred Shareholder or their appointees. The conversion shall take place at the sole discretion of the Holder of the Series B Preferred Shares. The Series B Preferred Shares, and the resulting Common Shares following Conversion, shall be included in the Company's next registration statement (SEC Registration, exemption or equivalent) following the date of Conversion.

b) Mechanics of Conversion.

(i) Holders of Series B Preferred Stock shall only be entitled to convert the shares of Series B Preferred Stock into shares of Common Stock upon the approval of holders, and shall surrender the certificate or certificates therefore, duly endorsed, at the office of the Corporation or of any transfer agent for the Series B Preferred Stock, and shall state therein the name or names in which the certificate or certificates for shares of Common Stock are to be issued. The Corporation shall, within ten (10) business days, issue and deliver at such office to the holders of Series B Preferred Stock, or to the nominee or nominees of such holder, a certificate or certificates for the number of shares of Common Stock to which such holder shall be entitled as aforesaid. If any holder fails to surrender the certificate, the holder's Series B Preferred Stock shall automatically convert and shares of Common Stock will be issued in the holder's name.

(ii) All Common Stock, which may be issued upon conversion of the Series B Preferred Stock, will, upon issuance, be duly issued, fully paid and non-assessable and free from all taxes, liens, and charges with respect to the issuance thereof.

6. Anti-Dilution Provisions.

During the period in which any shares of Series B Preferred Stock remain outstanding, the Conversion Formula in effect at any time and the number and kind of securities issuable upon the conversion of the Series B Preferred Stock shall be subject to adjustment from time to time following the date of the original issuance of the Series B Preferred Stock upon the happening of certain events as follows:

a) Consolidation, Merger or Sale. If any consolidation or merger of the Corporation with an unaffiliated third-party, or the sale, transfer or lease of all or substantially all of its assets to an unaffiliated third-party shall be effected in such a way that holders of shares of Common Stock shall be entitled to receive stock, securities or assets with respect to or in exchange for their shares of Common Stock, then provision shall be made, in accordance with this Section 6(a), whereby each holder of shares of Series B Preferred Stock shall thereafter have the right to receive such securities or assets as would have been issued or payable with respect to or in exchange for the shares of Common Stock into which the shares of Series B Preferred Stock held by such holder were convertible immediately prior to the closing of such merger, sale, transfer or lease, as applicable.

The Corporation will not effect any such consolidation, merger, sale, transfer or lease unless prior to the consummation thereof the successor entity (if other than the Corporation) resulting from such consolidation or merger or the entity purchasing or leasing such assets shall assume by written instrument (i) the obligation to deliver to the holders of Series B Preferred Stock such securities or assets as, in accordance with the foregoing provisions, such holders may be entitled to purchase, and (ii) all other obligations of the Corporation hereunder. The provisions of this Section 6(a) shall similarly apply to successive mergers, sales, transfers or leases. Holders shall not be required to convert Series B stock pursuant to this Section 6(a).

b) Notice of Adjustment. Whenever the Conversion Formula is adjusted as herein provided, the Corporation shall promptly but no later than 10 days after any request for such an adjustment by the holder, cause a notice setting forth the adjusted Conversion Formula issuable upon exercise of each share of Series B Preferred Stock, and, if requested, information describing the transactions giving rise to such adjustments, to be mailed to the holders at their last addresses appearing in the share register of the Corporation, and shall cause a certified copy thereof to be mailed to its transfer agent, if any. The Corporation may retain a firm of independent certified public accountants selected by the Board of Directors (who may be the regular accountants employed by the Corporation) to make any computation required by this Section 6, and a certificate signed by such firm shall be conclusive evidence of the correctness of such adjustment.

7. Voting Rights. The Shares of Series B Preferred Stock shall have no voting rights until converted into the Corporations Common Stock, except as otherwise required by law. The number of votes for the Series B Preferred Stock upon conversion, shall be the same number as the amount of shares of Common Stock that would be issued upon conversion of the Series B Preferred Stock pursuant to the Conversion Formula.

8. Status of Redeemed Stock. In the event the share of SERIES B Preferred Stock shall be redeemed pursuant to Section 4 hereof, or converted pursuant to Section 5 hereof, the share shall be cancelled and returned to the status of authorized but unissued shares of preferred stock.

9. Taxes. This Corporation will pay all taxes (other than taxes based upon income) and other governmental charges that may be imposed with respect to the issue or delivery of the share of SERIES B Preferred Stock.

------

## Ex1A-3

CERTIFICATE OF DESIGNATION, PREFERENCE AND RIGHTS OF SERIES A PREFERRED STOCK OF GOLD ENTERTAINMENT GROUP, INC.

Pursuant to the Business Organizations Law of the State of Wyoming

GOLD ENTERTAINMENT GROUP, Inc., a corporation organized and existing under the laws of the State of Wyoming (the "Corporation"), hereby certifies that the following resolutions were duly adopted by the Board of Directors of the Corporation by unanimous written consent on 1st February, 2023, pursuant to the authority vested in the Board of Directors by Article V of the Certificate of Incorporation of the Corporation which creates and authorizes five million (5,000,000) shares of Preferred SERIES A Stock of the Corporation, no par value (the Preferred SERIES A Shares):

Resolved, that pursuant to the authority vested in the Board of Directors by Article V of the Certificate of Incorporation of the Corporation, a series of Preferred Stock is hereby established, the distinctive designation of which shall be "Series A Preferred Shares" (such series being hereinafter called "Series A Preferred Shares"), and the preferences and relative, participating, optional or other special rights of the Series A Preferred Shares, and the qualifications, limitations or restrictions thereof (in addition to the relative powers, preferences and rights, and qualifications, limitations or restrictions thereof, set forth in the Corporation's Certificate of Incorporation which are applicable to shares of Preferred Stock of all series) shall be as follows:

1. Number of Shares; Stated Value and Dividends. The Corporation hereby designates one (1) share of the authorized shares of preferred stock as Series A Preferred Stock. The stated value of the Series A Preferred Stock shall be no par value. The holder of share of Series A Preferred Stock shall not be entitled to receive dividends.

2. Ranking The Series B Preferred Stock shall rank on parity with the Corporation's Common Stock and any class or series of capital stock of the Corporation hereafter created (the Parity Securities), in each case as to the distribution of assets upon liquidation, dissolution or winding up of the Corporation.

3. Liquidation Preference. In the event of any liquidation, dissolution or winding up of this Corporation, either voluntary or involuntary, the holder of Series A Preferred Shares may at his sole option elect to receive, prior and in preference to any distribution of any of the assets of this Corporation to the holders of common stock by reason of their ownership thereof, an amount per share equal to $0.001 for the outstanding share of Series A Preferred Stock. Upon the completion of this distribution and any other distribution that may be required with respect to series of preferred stock of this Corporation that may from time to time come into existence, if assets remain in this Corporation the holders of the common stock of this Corporation shall receive all of the remaining assets of this Corporation.

For purposes of this Section 3, a liquidation, dissolution or winding up of this Corporation shall be deemed to be occasioned by, or to include, (i) the acquisition of the Corporation by another entity by means of any transaction or series of related transactions including, without limitation, any reorganization, merger or consolidation but, excluding any merger effected exclusively for the purpose of changing the domicile of the Corporation or any transaction in which the Corporation is the surviving entity or (ii) a sale of all or substantially all of the assets of the Corporation unless the Corporation's shareholders of record as constituted immediately prior to such transaction will, immediately after such transaction (by virtue of securities issued as consideration in the transaction) hold at least 50% of the voting power of the surviving or acquiring entity. Whenever a distribution provided for in this Section 2 shall be payable in securities or property other than cash, the value of such distribution shall be the fair market value of such securities or other property as determined and agreed to by the Board of Directors of this Corporation.

4. Redemption. The Series A Preferred Stock is not redeemable without the prior written consent of the holder of such Series A Preferred Stock.

5. Conversion. The shares of Series A Preferred Stock are not convertible.

6. Voting Rights. The holder of the share of Series A Preferred Stock shall have the following voting rights:

(a) The holder of each share of Series A Preferred Stock shall be vote with the equivalent of one hundred (100) shares of Common Stock, in all voting matters. The holder of the share of Series A Preferred Stock shall be entitled to vote on all matters submitted to a vote of the shareholders of the Corporation, voting together with the holders of the common stock and of any other shares of capital stock of the Corporation entitled to vote at a meeting of shareholders as one class, except in cases where a separate or additional vote or consent of the holders of any class or series of capital stock or other equity securities of the Corporation shall be required by these Articles or applicable law, in which case the requirement for any such separate or additional vote or consent shall apply in addition to the single class vote or consent otherwise required by this paragraph.

(b) As of each record date for the determination of the Corporation's shareholders entitled to vote on any matter (a Record Date), the share of Series A Preferred Stock shall have votingrights and powers equal to the number of votes thatentitlethe holder of the shares of Series A Preferred Stock to exercise one vote to be cast as of such Record Date by all holders of capital stock of the Corporation so as toensure that the votes entitled to be cast by the holder of the shares of Series A Preferred Stock shall be equal to at least fifty-one percent (51%) of all votes entitled to be cast.

(c) Without the written consent of the holder of the share of Series A Preferred Stock at a meeting of the shareholders of this Corporation called for such purpose, the Corporation will not amend, alter or repeal any provision of the Articles of Incorporation (by merger or otherwise) so as to adversely affect the preferences, rights or powers of the Series A Preferred Stock.

7. Status of Redeemed Stock. In the event the share of Series A Preferred Stock shall be redeemed pursuant to Section 4 hereof, or converted pursuant to Section 5 hereof, the share shall be cancelled and returned to the status of authorized but unissued shares of preferred stock.

8. Taxes. This Corporation will pay all taxes (other than taxes based upon income) and other governmental charges that may be imposed with respect to the issue or delivery of the share of Series A Preferred Stock.

------

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 1-A

### REGULATION A OFFERING STATEMENT
### UNDER THE SECURITIES ACT OF 1933

### Item 1. Issuer Information

**Exact name of issuer:** GOLD ENTERTAINMENT GROUP INC

**Jurisdiction of Incorporation/Organization:** WY

**Year of Incorporation:** 1999

**CIK:** 0001081188

**I.R.S. Employer Identification Number:** 98-0206212

**Primary Standard Industrial Classification Code:** 3842

**Total number of full-time employees:** 19

**Total number of part-time employees:** 3

**Address of Principal Executive Offices:** 2412 IRWIN ST., —, MELBOURNE, FL 32901

**Company Phone:** 5612107553

**Person to contact:** HAMON FYTTON

### Financial Statements

**Balance Sheet Information**

| Metric                                   | Amount      |
|:---|:---|
| Cash and Cash Equivalents                | $9737.00    |
| Investment Securities                    | $0.00       |
| Accounts and Notes Receivable            | $26355.00   |
| Property, Plant and Equipment (PP&E)     | $0.00       |
| Total Assets                             | $142703.00  |
| Accounts Payable and Accrued Liabilities | $446991.00  |
| Long-Term Debt                           | $309919.00  |
| Total Liabilities                        | $756910.00  |
| Total Stockholders' Equity               | $-304288.00 |
| Total Liabilities and Equity             | $142703.00  |

**Statement of Comprehensive Income Information**

| Metric                                    | Amount     |
|:---|:---|
| Total Revenues                            | $559545.00 |
| Costs and Expenses Applicable to Revenues | $331787.00 |
| Depreciation and Amortization             | $0.00      |
| Net Income                                | $-89467.00 |
| Earnings Per Share - Basic                | 0.00       |
| Earnings Per Share - Diluted              | 0.00       |

**Auditor Information**

| Metric          | Amount   |
|:---|:---|
| Name of Auditor |  |

### Outstanding Securities

| Class    |   Outstanding | CUSIP     | Publicly Traded   |
|:---|---:|:---|:---|
| Common   |   16812001513 | 38059X206 | OTCMARKETS        |
| SERIES A |       2000000 | na        | na                |
| SERIES B |        272000 | na        | na                |

### Item 2. Issuer Eligibility
- [x] The issuer certifies that all of the statements in this part are true.

### Item 3. Application of Rule 262
- [x] The issuer certifies that it is not disqualified and has not been involved in any disqualifying event.

### Item 4. Summary Information Regarding the Offering

**Tier:** Tier1

**Financial Statement Status:** Unaudited

**Type of Securities Offered:** Equity (common or preferred stock)

**Is this a delayed or continuous offering?** Yes

**Was or is the offering to take place within one year after qualification?** No

**Was or is the offering to commence within two days after qualification?** No

**Is this a best efforts offering?** No

**Was there any solicitation of interest?** No

**Are there any resale securities by affiliates of the issuer?** Yes

**Offering Amounts**

| Description                                                     | Amount      |
|:---|:---|
| Number of securities offered                                    | 7000000000  |
| Number of securities outstanding                                | 16812001513 |
| Price per security                                              | $0.00       |
| Issuer's aggregate offering price                               | $735000.00  |
| Aggregate offering price of securities held by security holders | $315000.00  |
| Aggregate price of securities offered concurrently              | $0.00       |
| Total aggregate offering price                                  | $1050000.00 |

**Anticipated Fees**

| Service Provider   | Name   | Fees   |
|:---|:---|:---|
| Auditor            |  |  |
| Legal              |  |  |
| Promoters          |  |  |

**Estimated Net Proceeds to the Issuer:** —

### Item 5. Jurisdictions in Which Securities are to be Offered

AL, AK, AZ, AR, CA, CO, CT, DE, DC, FL, GA, HI, ID, IL, IN, IA, KS, KY, LA, ME, MD, MA, MI, MN, MS, MO, MT, NE, NV, NH, NJ, NM, NY, NC, ND, OH, OK, OR, PA, PR, RI, SC, SD, TN, TX, UT, VT, VA, WA, WV, WI, WY, A0, A1, A2, A3, A4, A5, A6, A7, A8, A9, B0, Z4